Ausgabe Sonderheft 2/2013 Proceedings of 20th Pediatric Rheumatology European Society (PReS) Congress
Inhalt (423 Artikel)
PReS13-SPK-1478: New developments in our care & understanding of JIA
- Open Access
- Invited speaker presentation
L Wedderburn
PReS13-SPK-1082: Catastrophic antiphospholipid syndrome
- Open Access
- Invited speaker presentation
R Cervera
PReS-FINAL-1004: Can the cd4/cd8β ratio be used as a predictive biomarker in extended-to-be oligoarticular JIA?
- Open Access
- Poster presentation
S de Leeuw, B Thirugnanabalan, H Varsani, F Warden, N Makengo, J Lewis, A Pesenacker, L Wedderburn
PReS-FINAL-1005: Hypertransaminasemia in systemic juvenile idiopathic arthritis during anti-interleukin 1 treatment
- Open Access
- Poster presentation
MI Gonzalez Fernandez, R Bou, R Silvia, E Iglesias, J Sánchez, V Torrente, J Antón
PReS-FINAL-1006: Autologous bone marrow transplantation in autoimmune, experimental arthritis restores immune homeostasis by renewal of the natural tregs compartment
- Open Access
- Poster presentation
T van den Broek, E Delemarre, J Meerding, E Wehrens, F Broere, N Wulffraat, M Boes, B Prakken, F van Wijk
PReS-FINAL-1007: Regulatory T cells functional specialization in JIA
- Open Access
- Poster presentation
G Mijnheer, B Prakken, FV Wijk
PReS-FINAL-1008: Areas of psychological assistance to children with severe disease during rehabilitation
- Open Access
- Poster presentation
A Buslaeva
PReS-FINAL-1009: Antioxidant superoxide dismutase activity is paradoxically normal in juvenile systemic lupus erythematosus
- Open Access
- Poster presentation
A Radziszewska, C Rowden, L Suffield, S Ursu, L Kassoumeri, LR Wedderburn, Y Ioannou
PReS-FINAL-1010: circulating micrornas in traps
- Open Access
- Poster presentation
OM Lucherini, M Ferracin, V Fulci, M McDermott, G Merlini, I Muscari, F Magnotti, LJ Dickie, M Galeazzi, M Negrini, CT Baldari, L Obici, R Cimaz, L Cantarini
PReS-FINAL-1011: Can repeated T cell receptor stimulation lead to epigenetic reprogramming of the treg-specific demethylated region in human conventional T cells?
- Open Access
- Poster presentation
Q Wu, D Bending, LR Wedderburn
PReS-FINAL-2007: Adolescent clinic for young patients with juvenile idiopathic arthritis
- Open Access
- Poster presentation
SK Sørensen
PReS-FINAL-2008: Juvenile dermatomyositis: a report of 22 cases
- Open Access
- Poster presentation
A Souto, N Alvarez, A Barros, L Fernandez, B Lopez, I Calvo
Pres-FINAL-2009: Pediatric rheumatology practitioners experience with biologics in juvenile dermatomyositis: survey results
- Open Access
- Poster presentation
A Patwardhan, K Rouster-Stevens, C Spencer
PReS-FINAL-2010: Predictive value of whole-body MRI in juvenile dermatomyositis
- Open Access
- Poster presentation
C Malattia, A Madeo, M Dellepiane, A Pistorio, MB Damasio, S Viola, S Pederzoli, A Beltramo, D Beleva, A Consolaro, A Martini
PReS-FINAL-2011: Preliminary validation of a new hybrid measure of muscle strength for juvenile dermatomyositis
- Open Access
- Poster presentation
D Marafon, A Consolaro, C Ferrari, S Dalprà, A Madeo, A Providenti, C Malattia, N Ruperto, A Civino, A Martini, A Ravelli
PReS-FINAL-2012: Introducing a new approach to clinical care of juvenile dermatomyositis: the juvenile dermatomyositis multidimensional assessment report
- Open Access
- Poster presentation
GC Varnier, C Ferrari, A Consolaro, D Marafon, C Pilkington, S Maillard, M Jelusic Drazic, S Dalpra', A Civino, A Martini, A Ravelli
PReS-FINAL-2013: Sodium thiosulfate for the treatment of Juvenile Dermatomyositis complicated by calcinosis
- Open Access
- Poster presentation
I Pagnini, G Simonini, T Giani, L Cantarini, R Cimaz
PReS-FINAL-2014: Excellent results of the conventional treatment in a child with late-diagnosed juvenile dermatomyositis with severe calcinosis
- Open Access
- Poster presentation
IP Nikishina, SV Arsenyeva, AN Shapovalenko
PReS-FINAL-2015: Demographic, clinical and laboratory features of juvenile dermatomyositis in Croatia: retrospective study over the last 22 years
- Open Access
- Poster presentation
M Frković, I Malčić, I Rukavina, V Rožmanić, K Markičević, N Turjak, M Jelušić
PReS-FINAL-2016: Bone mineral status in a long-term follow up of juvenile dermatomyositis patients
- Open Access
- Poster presentation
VA Kristensen, S Nielsen, T Herlin, P Mathiesen
PReS-FINAL-2017: Systemic onset juvenile idiopathic arthritis (SOJIA)-a 5-year survey in a pediatric rheumatology department
- Open Access
- Poster presentation
A Čengić, A Omerčahić Dizdarević, V Selmanović, S Mesihović Dinarević
PReS-FINAL-2018: The P53 gene polymorphisms and juvenile idiopathic arthritis
- Open Access
- Poster presentation
A Kozhevnikov, N Pozdeeva, M Konev, M Nikitin, V Larionova, G Novik, M Slyndev
PReS-FINAL-2019: Tuberculosis infection observed in patients receiving biological DMARDs for treatment of juvenile idiopathic arthritis
- Open Access
- Poster presentation
A Sarychev, L Shovkun
PReS-FINAL-2020: Cell type specific transcriptome analysis in patients with enthesitis related arthritis category of juvenile idiopathic arthritis (JIA-ERA)
- Open Access
- Poster presentation
A Aggarwal, A Myles, P Gaur
PReS-FINAL-2021: JADAS-CRP instead of JADAS-ESR...results from REUMA.PT
- Open Access
- Poster presentation
AF Mourão, MJ Santos, J Melo Gomes, F Martins, JA Costa, F Ramos, I Brito, C Duarte, R Figueira, G Figueiredo, C Furtado, A Lopes, M Oliveira, A Rodrigues, M Salgado, M Sousa, J Branco, J Eurico Fonseca, H Canhão
PReS-FINAL-2022: Juvenile idiopathic arthritis after allogeneic bone marrow transplantation: a case report
- Open Access
- Poster presentation
E Tronconi, A Miniaci, A Pession
PReS-FINAL-2023: Uveitis surveillance through lean-six sigma for quality assurance in juvenile idiopathic arthritis
- Open Access
- Poster presentation
A Patwardhan, K Kelleher, K Jones, S Ardoin, C Spencer
PReS-FINAL-2024: Responsiveness of the juvenile arthritis foot disability index
- Open Access
- Poster presentation
AC Esbjörnsson, MD Iversen, EW Broström, S Hagelberg, M André
PReS-FINAL-2025: Arthritis associated with human immunodeficiency virus
- Open Access
- Poster presentation
AE Bean, M Al-Obaidi, F Shakley, C Waruiru, D Hawley
PReS-FINAL-2026: Glucose and lipid metabolism in children with juvenile idiopathic arthritis treated with anti-TNF-alpha
- Open Access
- Poster presentation
AE Christensen, AJ Schou
PReS-FINAL-2027: Cerebral demyelination and optic neuritis during treatment with eternacept and methotrexate
- Open Access
- Poster presentation
AE Christensen, L Bistrup, P Toftedal
PReS-FINAL-2028: ANA positivity and a younger age at onset, but not disease category, predict the risk of uveitis in italian children with juvenile idiopathic arthritis
- Open Access
- Poster presentation
B Schiappapietra, S Calandra, MC Gallo, R De Marco, V Muratore, S Lanni, A Consolaro, A Martini, A Ravelli
PReS-FINAL-2029: Long-term follow-up of patients with juvenile idiopathic arthritis (JIA) in a single center: a systematic chart review
- Open Access
- Poster presentation
BE Bica, DS Bastos, TA Nogueira
PReS-FINAL-2030: Treatment with leflunomide results in a higher flare rate of chronic uveitis compared to methotrexate in patients with juvenile idiopathic arthritis treated with both drugs
- Open Access
- Poster presentation
J Bichler, M Krumrey-Langkammerer, JP Haas, B Hugle
PReS-FINAL-2031: Hyaluronic acid is a marker of active arthritis, but not systemic inflammation in systemic juvenile idiopathic arthritis
- Open Access
- Poster presentation
B Hugle, M Olsson, N Fischer, M Herrmann, K Lindblad-Toh, JP Haas
PReS-FINAL-2032: Changes in immunogenic profile in patients with juvenile idiopathic arthritis exposed to anti tumoral necrosis factor therapy
- Open Access
- Poster presentation
CA Guillen Astete, WA Sifuentes Giraldo, ML Gamir
PReS-FINAL-2033: Increase of adverse mild and moderate adverse events among patients with juvenile idiopathic arthritis treated with biological therapies
- Open Access
- Poster presentation
CA Guillen Astete, L García Campayo, B Conde Campayo, A Sifuentes Giraldo, ML Gamir Gamir
PReS-FINAL-2034: Α1 - Antitrypsin deficiency in children with arthritis: four cases
- Open Access
- Poster presentation
C Pruunsild, J Ilisson
PReS-FINAL-2035: Fatty acid profiling: potential new biomarkers in JIA
- Open Access
- Poster presentation
C Boros, WT CHAM, J Fletcher, E Ranieri
PReS-FINAL-2036: Proteins of the lectin pathway of the complement system in juvenile idiopathic arthritis
- Open Access
- Poster presentation
C Petri, S Thiel, JC Jensenius, B Kuno-Møller, T Herlin
PReS-FINAL-2037: Association between clinical and microbiological periodontal condition in Colombian patients with juvenile idiophatic arthritis
- Open Access
- Poster presentation
C Malagon, C Romero, C Vargas, J De Avila, GI Lafaurie, DM Castillo, AC Mosquera
PReS-FINAL-2038: Clinical efficacy and tolerability of tocilizumab in patients with persistant systemic JIA
- Open Access
- Poster presentation
D Mihailova, B Varbanova, S Stefanov, A Teltcharova
PReS-FINAL-2039: Evaluation of local activity of wrists and finger joints damage in patients with juvenile idiopathic arthritis: the values of radiology methods
- Open Access
- Poster presentation
D Alekseev, I Nikishina, A Smirnov, O Pushkova, A Volkov
PReS-FINAL-2040: Outcome of macrophage activation syndrom (MAS) in systemic juvenile idiopatic arthritis (SJIA) in non biologic treated patient
- Open Access
- Poster presentation
DS Lazarevic, J Vojinovic
PReS-FINAL-2041: Macrophage activation syndrome in the children with systemic juvenile idiopathic arthritis during the course of tocilizumab
- Open Access
- Poster presentation
E Alekseeva, R Denisova, S Valieva, T Bzarova, K Isayeva, T Sleptsova, EA Mitenko, E Chistyakova, A Fetisova
PReS-FINAL-2042: Health-related quality of-life in Turkish children and adolescents with juvenile idiopathic arthritis
- Open Access
- Poster presentation
E Tarakci, SN Baydogan, O Kasapcopur
PReS-FINAL-2043: Cardiac involvement in juvenile idiopathic arthritis
- Open Access
- Poster presentation
E Rossetto, E Benelli, E Mascheroni, E Berton, A Taddio, L Lepore
PReS-FINAL-2044: TNF-alpha inhibitors in treatment of children with systemic form of juvenile idiopathic arthritis
- Open Access
- Poster presentation
ES Zholobova, OU Konopelko, MN Nikolaeva, OS Rozvadovskaya
PReS-FINAL-2045: Mutational analysis of sialic acid acetylesterase (siae) in juvenile idiopathic arthritis (JIA)
- Open Access
- Poster presentation
E Tsitsami, E Sevdali, M Speletas
PReS-FINAL-2046: Uveitis in the Nordic juvenile idiopathic arthritis cohort; high incidence, frequent complications, and gender-associated risk factors
- Open Access
- Poster presentation
EB Nordal, L Berntson, K Aalto, S Peltoniemi, S Nielsen, T Herlin, A Fasth, M Rygg
PReS-FINAL-2047: Exploring the effectiveness of stretch and cast treatment of fixed flexion deformity in children with active JIA
- Open Access
- Poster presentation
E Haggart, S Maillard
PReS-FINAL-2048: Treatment with methotrexate plus leflunomide for juvenile idiopathic arthritis
- Open Access
- Poster presentation
E Quesada-Masachs, C Modesto
PReS-FINAL-2050: Determination of the concentration of methotrexate in the blood serum of patients with JIA
- Open Access
- Poster presentation
F Rokhlina, G Novik
PReS-FINAL-2051: The difference of disease's perception by JIA patients and their parents: analysis of the JAMAR questionnaire
- Open Access
- Poster presentation
F Vanoni, B Fonjallaz, G Lucie, A von Scheven-Gête, M Hofer
PReS-FINAL-2052: Costs of biologics in juvenile idiopathic arthritis: past, present and future
- Open Access
- Poster presentation
FH Prince, LW van Suijlekom-Smit
PReS-FINAL-2053: Vitamin D receptor polymorphisms in a cohort of Italian patients with juvenile idiopathic arthritis
- Open Access
- Poster presentation
F Falcini, F Marini, D Rigante, F Bertini, G Lepri, S Stagi, M Matucci Cerinic, ML Brandi
PReS-FINAL-2054: Latent tuberculosis infection in patients with juvenile idiopathic arthritis undergoing methotrexate therapy: a longitudinal study with TST and ELISPOT
- Open Access
- Poster presentation
F Sztajnbok, NL Boechat, SK Oliveira, SB Ribeiro, MC Rodrigues, C Diniz, FCDN Sztajnbok, CC Sant'Anna
PReS-FINAL-2055: Is there a necessity for patients with JIA to wear orthopedic insoles?
- Open Access
- Poster presentation
F Kreuzpointner, M Hartmann, A Schwirtz, JP Haas
PReS-FINAL-2057: Systemic onset JIA with coronary artery dilatation
- Open Access
- Poster presentation
N Aktay Ayaz, G Keskindemirci, N Melikoglu, E Aldemir, G Aydogan
PReS-FINAL-2058: Lipid peroxides, lipophuscin, sulfhydryl groups and TOS in children with JIA
- Open Access
- Poster presentation
H Mazur Zielinska, M Zielinski, D Karbowska, L Pilarz, E Birkner
PReS-FINAL-2059: Th17 cells highly enriched in peripheral blood in children with HLA B27-associated arthritis and systemic onset juvenile idiopathic arthritis
- Open Access
- Poster presentation
I Turtsevich
PReS-FINAL-2060: The role of stress factors in the onset of juvenile idiopathic arthritis
- Open Access
- Poster presentation
N Stepanenko, T Shelepina, I Nikishina
PReS-FINAL-2061: Abatacept in therapy of juvenile idiopathic arthritis in real clinical practice
- Open Access
- Poster presentation
SV Arsenyeva, IP Nikishina, MI Kaleda, DL Alekseev, LG Medyntceva, SR Rodionovskaya
PReS-FINAL-2062: The need for conducting different rehabilitation complexes for patients with juvenile idiopathic arthritis (JIA)
- Open Access
- Poster presentation
TA Shelepina, IP Nikishina
PReS-FINAL-2063: Proposed criteria for activity, damage and impact of juvenile idiopathic arthritis associated uveitis: consensus effort from the multinational interdisciplinary working group for uveitis in childhood (MIWGUC)
- Open Access
- Poster presentation
I Foeldvari, A Heiligenhaus, J Anton, R Ramanan, C Edelsten, T Saurenmann, B Bodaghi, K Kotaniemi, S Nielsen, E Rabinovich
PReS-FINAL-2064: Effect of Goloimumab a new anti-TNF, in patients with the diagnosis of juvenile idiopathic arthritis
- Open Access
- Poster presentation
A Kienast, I Foeldvari
PReS-FINAL-2065: Oxidative stress is associated to disease activity in a large cohort of JIA at transitional period
- Open Access
- Poster presentation
J Wipff, C Deslandre, C Gobeaux, A Kahan, D Borderie
PReS-FINAL-2066: Use of chiropractic care in danish children with juvenile idiopathic arthritis
- Open Access
- Poster presentation
KS Kuhn, AJ Schou, AE Christensen
PReS-FINAL-2067: How does the self-experienced HRQOL work for children with JIA - juvenile idiopathic arthritis in Stockholm?
- Open Access
- Poster presentation
K Berggren
PReS-FINAL-2068: S100 A8/A9 serum levels reflect disease activity in juvenile idiopathic arthritis-associated uveitis
- Open Access
- Poster presentation
K Walscheid, D Holzinger, C Heinz, C Arnold, D Bauer, M Busch, M Hennig, S Wasmuth, J Roth, A Heiligenhaus, D Foell
PReS-FINAL-2069: T cells secreting granulocyte-macrophage colony stimulating factor (GM-CSF) within the inflammed joint originate from an "EX-Th17" population
- Open Access
- Poster presentation
K Nistala, C Piper, A Pesenacker, D Bending, B Thirugnanabalan, L Wedderburn
PReS-FINAL-2070: Efficacy of biologic treatments in juvenile idiopathic arthritis with a polyarticular course: an indirect comparison
- Open Access
- Poster presentation
L Sawyer, A Diamantopoulos, HI Brunner, F De Benedetti, N Ruperto, F Dejonckheere, C Keane
PReS-FINAL-2071: Anti-type II collagen antibodies, anti-CCP, IgA-RF and IgM-RF are associated with joint damage eight years after onset of juvenile idiopathic arthritis (JIA)
- Open Access
- Poster presentation
L Berntson, K Aalto, A Fasth, T Herlin, S Nielsen, E Nordal, M Rygg, J Rönnelid
PReS-FINAL-2072: How does the management of enthesitis related arthritis differ from other sub-types of juvenile idiopathic arthritis? A retrospective study of jia at an adolescent rheumatology centre
- Open Access
- Poster presentation
M Choudhury, D Sen, J Ioannou
PReS-FINAL-2073: The usefulness of musculoskeletal ultrasound in monitoring efficacy of intraarticular infliximab therapy in JIA patients
- Open Access
- Poster presentation
M Vidovic, M Perica, L Lamot, L Tambic Bukovac, M Harjacek
PReS-FINAL-2074: The role of the probiotic VSL-3 as adjuvant therapy in patients with undifferentiated spondyloarthritis (ERA)
- Open Access
- Poster presentation
M Vidovic, M Perica, L Lamot, M Zaninovic, L Tambic Bukovac, M Harjacek
PReS-FINAL-2075: Biologic response modifiers: usage and safety profile from a North Indian pediatric rheumatology centre
- Open Access
- Poster presentation
M Agarwal, M Jariwala, S Sawhney
PReS-FINAL-2076: Single centre experience of biologics in clinical practice of systemic juvenile idiopatic arthritis
- Open Access
- Poster presentation
MI Kaleda, IP Nikishina, SR Rodionovskaya, AN Shapovalenko
PReS-FINAL-2077: Lung function evaluation in a juvenile idiopathic arthritis cohort
- Open Access
- Poster presentation
I Machado Vaz, M Rodrigues, I Azevedo, J Winck, I Brito
PReS-FINAL-2078: Single nucleotide polymorphisms of toll like receptors 2 and 4 in enthesitis related arthritis and oligo and polyarticular juvenile idiopathic arthritis
- Open Access
- Poster presentation
M Perica, M Perić, M Vidović, L Tambić Bukovac, L Lamot, J Barbić, M Harjaček
PReS-FINAL-2079: Will cooling an arthritic joint cause damage? - an analysis of different cooling methods in patients with jia using thermography
- Open Access
- Poster presentation
M König, F Kreuzpointner, M Hartmann, M Georgi, HJ Händel, A Schwirtz, JP Haas
PReS-FINAL-2080: Overlap syndrome between primary sclerosing cholangitis and autoimmune hepatitis associated with ulcerative colitis - a case of unusual presentation in a patient with systemic juvenile idiopathic arthritis
- Open Access
- Poster presentation
M Cabral, S Batalha, J Nunes, R Jotta, M Cravo, P Oom
PReS-FINAL-2081: Accelerometer-assessed daily activity in juvenile idiopathic arthritis
- Open Access
- Poster presentation
M Noergaard, J Svensson, LB Andersen, T Herlin
PReS-FINAL-2082: Reliability and responsiveness of the standardized universal pain evaluations for rheumatology providers for children and youth (SUPER-KIDZ)
- Open Access
- Poster presentation
N Luca, J Stinson, BM Feldman, S Benseler, D Beaton, AM Bayoumi
PReS-FINAL-2083: The rate of malignancy in iranian children with joint manifestations
- Open Access
- Poster presentation
N Shafaie, Y Aghighi, SR Raeeskarami, A Malek, MR Nesabi, A Izadpanah, B Nourbakhsh, SH Faghihi, Z Oloomi-Yazdi, P Vosough
PReS-FINAL-2084: Prevalence of cervical spine involvement in children with juvenile idiopathic arthritis
- Open Access
- Poster presentation
N Semolič, N Toplak, J Koder, D Ključevšek, T Avčin
PReS-FINAL-2085: The p38-mediated rapid downregulation of cell surface gp130 expression impairs IL-6 signaling in the synovial fluid of juvenile idiopathic arthritis patients
- Open Access
- Poster presentation
N Honke, K Ohl, A Wiener, N Wagner, S Wüller, K Tenbrock
PReS-FINAL-2086: In vitro investigation of the sustained therapeutic effect of etanercept loaded microspheres on human rheumatoid arthritis fibroblast-like synoviocytes
- Open Access
- Poster presentation
O Erdemli, S Ozen, C Kocaefe, A Usanmaz, ED Batu, B Atilla, D Keskin, A Tezcaner
PReS-FINAL-2087: Diagnosis of arthritis: history or laboratory?
- Open Access
- Poster presentation
O Yurtsever, K Gulleroglu, US Bayrakci, A Kantar, E Baskin
PReS-FINAL-2208: Sacroilitis with propionibacterium acnes in a child
- Open Access
- Poster presentation
C Galeotti, I Koné-Paut
PReS-FINAL-2209: MEFV gene mutations in central and south-eastern European countries
- Open Access
- Poster presentation
D Perko, M Debeljak, N Toplak, A Sediva, T Dallos, M Harjaček, M Jelušič, G Ristić, B Dérfalvi, K Mironska, S Rusoniene, D Kuzmanovska, N Kurjane, M Bataneant, T Avčin
PReS-FINAL-2210: Qualitative aspects of autoinflammatory diseases
- Open Access
- Poster presentation
D Konukbay, D Yildiz, C Acikel, D Karaman, B Fidanci, Y Bilginer, I Kone-Pau, J Frenkel, M Gottorno, S Ozen, E Demirkaya
PReS-FINAL-2211: NOD2/CARD15 polymorphisms and clinical features in patients with non-infectious uveitis
- Open Access
- Poster presentation
E Marrani, R Cimaz, OM Lucherini, R Caputo, A Vitale, L Cantarini, G Simonini
PReS-FINAL-2212: Mevalonate kinase deficiency: different faces with separate treatments
- Open Access
- Poster presentation
P Gençpınar, E Ünsal, B Makay
PReS-FINAL-2213: Validation of inadequate drug response and definition of colchicum resistance in FMF
- Open Access
- Poster presentation
E Demirkaya, C Acikel, G Basbozkurt, A Gul, O Kasapcopur, O Aydog, H Erdem, A Duzova, B Kisacik, T Kasifoglu, E Erken, M Tunca, M Sayarlioglu, S Yuksel, F Yildiz, O Donmez, A Berdeli, S Senel, NA Ayaz, A Polat, B Sozer, Y Tabel, S Akar, AM Onat, O Ozkaya, S Emre, N Akinca, G Ozcelik, S Yavuz, S Yesilkaya, F Gok, HM Poyrazoglu, H Direskeneli, S Bakkaloglu, S Erten, A Tufan, B Goker, S Kavukcu, N Cakar, M Saldir, A Delibas, B Makay, A Kısaarslan, SE Unsal, H Ozdogan, R Topaloglu, S Ozen
PReS-FINAL-2214: Validation of new pediatric criteria in diagnosis of Familial Mediterranean Fever in children
- Open Access
- Poster presentation
E Baskin, US Bayrakci, N Akyol, K Gulleroglu, A Kantar, O Yurtseven, F Şahin
PReS-FINAL-2215: Genotype-phenotype correlations in children with Familial Mediterranean Fever in Germany
- Open Access
- Poster presentation
F Gohar, M Jeske, P Lohse, T Kallinich, U Neudorf, T Niehues, H Wittkowski, E Lainka, D Foell
PReS-FINAL-2216: Biomarkers MRP8/14 and S100A12 correspond with flare and remission clinical status in Sojia patients in the AID-NET register
- Open Access
- Poster presentation
F Gohar, E Husmann, PJ Haas, G Horneff, H Wittkowski, D Holzinger, T Kallinich, U Neudorf, T Niehues, E Lainka, D Foell
PReS-FINAL-2217: Atypical presentation of CRMO in two children
- Open Access
- Poster presentation
F Vanoni, A Von Scheven-Gête, M Hofer
PReS-FINAL-2218: Treatment of colchicines resistant FMF: experience of a pediatric center in Turkey
- Open Access
- Poster presentation
F Kara Eroglu, Y Bilginer, F Ozaltin, R Topaloglu, S Ozen
PReS-FINAL-2219: Evaluation of autonomic function in FMF
- Open Access
- Poster presentation
N Aktay Ayaz, N Melikoglu, G Keskindemirci, G Aydogan, O Isal Tosun, A Güzeltaş, E Odemis
PReS-FINAL-2220: Cochlear involvement in FMF
- Open Access
- Poster presentation
G Keskindemirci, N Aktay Ayaz, A Batioglu, G Aydogan, E Aldemir, Z Dönmez, Ö Yiğit, S Ozen
PReS-FINAL-2221: An earliest diagnosis of FMF
- Open Access
- Poster presentation
G Keskindemirci, N Aktay Ayaz, E Aldemir, C Aydogmus, G Aydogan, S Kavuncuoglu
PReS-FINAL-2222: FMF presenting with the features of malignancy
- Open Access
- Poster presentation
G Keskindemirci, N Aktay Ayaz, D Tugcu, A Akcay, E Aldemir, G Aydogan
PReS-FINAL-2223: The relationship between FMF, BD and epilepsy
- Open Access
- Poster presentation
H Sargsyan
PReS-FINAL-2224: Canakinumab treatment regimens in CAPS-patients
- Open Access
- Poster presentation
F Hofer, T Endres, B Kortus-Götze, N Blank, E Weißbarth-Riedel, C Schütz, T Kallinich, K Krause, C Rietschel, G Horneff, J Kuemmerle-Deschner
PReS-FINAL-2225: Oxidative stress in children with episodic fever of unknown origin
- Open Access
- Poster presentation
J Vojinovic, J Radovic, D Lazarevic, T Jeftic-Stoimenov, D Pavlovic
PReS-FINAL-2226: Assessment of autonomic functions in children with Familial Mediterranean Fever by using heart rate variability measurements
- Open Access
- Poster presentation
K Fidanci, M Gulgun, A Kilic, C Acikel, E Demirkaya, F Gok, S Ozen
PReS-FINAL-2227: QT and JT dispersion in children with FMF
- Open Access
- Poster presentation
K Fidanci, A Kilic, M Gulgun, C Acikel, G Basbozkurt, E Demirkaya, F Gok
PReS-FINAL-2228: Survey of off-label ANTI-IL1 treatments in France: two years data
- Open Access
- Poster presentation
L Rossi-Semerano, B Fautrel, D Wendling, E Hachulla, C Galeotti, A Meyer, S Ottaviani, R Dhote, O Richer, M Fouillet-Desjonqueres, I Touitou, I Koné-Paut
PReS-FINAL-2229: Pamidronate in CRMO - a small case series
- Open Access
- Poster presentation
M Schuller, J Franova, M Macku
PReS-FINAL-2230: A prospective evaluation of a cohort of patients with PFAPA syndrome
- Open Access
- Poster presentation
M Cattalini, I Bosio, A Meini, P Cancarini, M Berlucchi, G Savoldi
PReS-FINAL-2231: A series of 41 mutations of TNFRAF1A
- Open Access
- Poster presentation
MC Chastang, M Desjonqueres, V Hentgen, P Quartier Dit Maire, G Grateau, I Kone-Paut, I Durieu, J Ninet, P Cochat
PReS-FINAL-2232: Long-term follow-up in a national cohort of MKD patients: search for clinical predictors of a spontaneous improvement
- Open Access
- Poster presentation
M Doglio, S Federici, A Tommasini, A Meini, M Cattalini, L Obici, L Cantarini, F Zulian, L Breda, R Consolini, F Corona, A Insalaco, D Rigante, A Martini, M Gattorno
PReS-FINAL-2233: Retrospective analysis of different treatment strategies in chronic non-bacterial osteomyelitis
- Open Access
- Poster presentation
MM Kostik, IA Chikova, MF Dubko, LS Snegireva, VV Masalova, OV Kalashnikova, AY Mushkin, VG Chasnyk
PReS-FINAL-2234: Successful canakunimab treatment in uveitis secondary to cryopyrin-associated periodic syndrome
- Open Access
- Poster presentation
O Kasapcopur, I Tugal-Tutkun, K Barut, T Erener-Ercan, A Gul
PReS-FINAL-2235: Overlap of homozygous TNFRSF1A R92Q mutation with MEVF E148Q mutation versus homozygous TNFRSF1A R92Q mutation: difference in clinical profile in two sisters from Oman
- Open Access
- Poster presentation
R Abdwani, S Abrawi, E Ibraheem, K Al Thuhli
PReS-FINAL-2236: Continuous autoinflammatory syndromes: a single-center experience in Argentina
- Open Access
- Poster presentation
RA Russo, MM Katsicas
PReS-FINAL-2237: The diagnostic challenge of osteolytic bone lesions in autoinflammatory diseases: a case report
- Open Access
- Poster presentation
R Caorsi, P Picco, A Buoncompagni, S Signa, F Minoia, S Federici, A Martini, M Gattorno
PReS-FINAL-2238: PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome: results from the Eurofever registry
- Open Access
- Poster presentation
R Caorsi, A Insalaco, D Marotto, J Frenkel, A Martini, F De benedetti, M Gattorno
PReS-FINAL-2239: Renal AA amyloidosis in a child with hyper-IgD syndrome and a novel MVK mutation
- Open Access
- Poster presentation
S Fingerhutova, A Kolsky, D Rowczenio, H Lachmann, Z Vernerova, F Votava, P Dolezalova
PReS-FINAL-2240: Serum amyloid protein a concentration in CAPS patients treated with anti IL1Β
- Open Access
- Poster presentation
S Pastore, G Paloni, M Gattorno, A Taddio, L Lepore
PReS-FINAL-2241: Cases of cryopyrin-associated periodic syndromes (CAPS) in one single rheumatologic center of Russia
- Open Access
- Poster presentation
SO Salugina, E Fedorov, N Kuzmina, E Zaharova
PReS-FINAL-2242: Familial Mediterranean Fever - first experiences in Slovakia
- Open Access
- Poster presentation
T Dallos, L Lukáčiková Gálová, E Macejková, N Toplak, M Debeljak, L Kovács
PReS-FINAL-2243: Reduced volumetric trabecular bone mineral density in children with idiopathic hypercalciuria. A peripheral quantitative computed tomography (PQCT) study (preliminary results)
- Open Access
- Poster presentation
E Atsali, KD Stathopoulos, I Bournazos, P Nicolaidou, P Papaggelopoulos, G Skarantavos
PReS-FINAL-2244: Ultrasound examination reveals typical alterations in joints of mucopolysaccharidosis (MPS) patients
- Open Access
- Poster presentation
N Karabul, M Beck, A Solyom, E Mengel, C Lampe
PReS-FINAL-2245: A rare case of subcutaneous panniculitis-like T cell lymphoma in a 9-month-old child
- Open Access
- Poster presentation
A Kozlova, D Abramov Dmitriy, N Miakova, A Maschan, A Shcherbina
PReS-FINAL-2246: CBCT versus orthopan tomogram detecting TMJ alteration in JIA
- Open Access
- Poster presentation
P Arvonen, J Naujokaityte, M Arvonen, J Niinimäki, P Vähäsalo, P Pirttiniemi
PReS-FINAL-2247: Confidence of UK general peadiatric trainees in musculoskeletal clinical assessment and preferences for future teaching resources
- Open Access
- Poster presentation
E Smith, M Cruikshank, H Dean, HE Foster, S Jandial
PReS-FINAL-2248: Parovirus B19 associated unusual joint symptoms in twin girls
- Open Access
- Poster presentation
H Sakalli, E Baskin, S Dener
PReS-FINAL-2249: A national survey of the role of the paediatric rheumatology nurse in performing steroid joint injections in the UK
- Open Access
- Poster presentation
H Lee, D Hawley, J Edgerton, M Al-Obaidi
PReS-FINAL-2250: Presentation of tuberculosis in patients using anti-TNFS drugs: report of 3 cases
- Open Access
- Poster presentation
BE Bica, LM Saldarriaga Rivera, H Tupinambá, MNL Azevedo
PReS-FINAL-2251: Influenza myositis outbreaks: clinical and laboratory findings
- Open Access
- Poster presentation
SP Cardin, TP Fernandes, JG Martin, LAL Resende, CS Magalhaes
PReS-FINAL-2252: Descriptive analysis of pediatric autoimmune neuropsychiatric disorder associated with streptococcus infection (PANDAS) in a cohort of 65 Italian patients
- Open Access
- Poster presentation
F Falcini, G Lepri, D Rigante, F Bertini, M Matucci Cerinic
PReS-FINAL-2253: A case series of HIV arthropathy in Cape Town
- Open Access
- Poster presentation
K Webb, C Scott, N Brice
PReS-FINAL-2254: Is it systemic JIA or post infectious illness?
- Open Access
- Poster presentation
P Guddeti, Z Ahmed, M Yiallourides
PReS-FINAL-2255: Primary pyomiositis in children: a challenging diagnosis
- Open Access
- Poster presentation
V Moressa, S Pastore, M Pavan, C Bracaglia, L Lepore
PReS-FINAL-2256: Panniculitis revealing quantitative alpha 1 antitrypsine deficiency
- Open Access
- Poster presentation
A Gagro, N Pustišek, J Čepin Bogović, A Rožman, E Ozimec, AM Kapović
PReS-FINAL-2257: Pediatric rheumatology in a rare disease working group: examples of diagnoses
- Open Access
- Poster presentation
A Solyom, B Mosdósi, Z Nyul, K Komlósi
PReS-FINAL-2258: Final diagnoses of pediatric patients presenting with musculoskeletal symptoms in a center from the eastern Mediterranean
- Open Access
- Poster presentation
O Cavkaytar, A Duzova, O Teksam, G Kale, S Ozen
PReS-FINAL-2259: Spectrum of Sjögren syndrome in children
- Open Access
- Poster presentation
BE Bica, LM Saldarriaga Rivera, H Tupinambá, MNL Azevedo
PReS-FINAL-2260: Provisional findings of an on-going study of musculoskeletal anomalies in a national cohort of patients with trisomy 21
- Open Access
- Poster presentation
C Foley, OG Killeen
PReS-FINAL-2261: Prevalence of orofacial symptoms and signs in patients with juvenile fibromyalgia
- Open Access
- Poster presentation
C Len, L Zwir, M Fraga, MT Terreri
PReS-FINAL-2262: Arthritis in a patient with type 1 glycogen storage disease
- Open Access
- Poster presentation
E Baskin, US Bayrakci, H Sakallı, A Kantarcı, F Ozcay
PReS-FINAL-2263: Progressive pseudorheumatoid dysplasia in differential diagnosis of juvenile idiopathic arthritis
- Open Access
- Poster presentation
E Vrtíková, E Košková, M Genčík, J Sedlákova
PReS-FINAL-2264: Three middle fingers width correlates with maximum mouth opening and is a reliable parameter to identify joint hypermobility in schoolchildren
- Open Access
- Poster presentation
F Sperotto, G La Falce, F Vittadello, M Balzarin, L Favero, F Zulian
PReS-FINAL-2265: Tuberculosis in pediatric patients who are receiving anti-TNF agents
- Open Access
- Poster presentation
J Calzada-Hernández, A Noguera Julian, S Ricart Campos, R Bou Torrent, E Iglesias Jiménez, MI González Fernández, J Sánchez Manubens, V Torrente Segarra, L Rozas Quesada, FJ Martín Carpi, J Antón López
PReS-FINAL-2266: A rare cause for childhood uveitis: TINU (tubulointerstitial nephritis and uveitis) syndrome
- Open Access
- Poster presentation
K Barut, T Rızayev, A Yurt, I Tugal-Tutkun, S Çalışkan, N Canpolat, L Sever, O Kasapcopur
PReS-FINAL-2267: Successful treatment of pulmonary arterial hypertension associated with connective tissue disease (PAH-CTD) with combination therapy of sildenafil and ambrisentan: a case report
- Open Access
- Poster presentation
KI Yamaguchi, M Kishimoto, M Okada
PReS-FINAL-2268: Sarcoidosis in children seen at the pediatric rheumatology clinics of two referral hospitals in Cape Town, South Africa
- Open Access
- Poster presentation
LO Okong'o, C Scott, K Webb
PReS-FINAL-2269: Incidence of antiphospholipid antibody syndrome in a cohort of children suffering from either arterial or venous thrombosis
- Open Access
- Poster presentation
P Cancarini, M Cattalini, I Bosio, M Marchini, S Vitari, A Meini
PReS-FINAL-2270: Primary hypertrophic osteoarthropathy - a rare cause of swollen joints
- Open Access
- Poster presentation
M Rodrigues, I Brito
PReS-FINAL-2271: Assessment of musculoskeletal abnormalities in children with mucopolysaccharidoses using a simple musculoskeletal examination (paediatric gait, arms, legs and spine)
- Open Access
- Poster presentation
MO Chan, ES Sen, E Hardy, T Rapley, P Hensman, E Wraith, H Foster
PReS-FINAL-2272: Association of benign joint hypermobility syndrome with mitral valve prolapsed in Iranian children
- Open Access
- Poster presentation
R Shiari, F Vaziri, E Zahmatkesh, H Javaherizadeh
PReS-FINAL-2273: Clinical and laboratory characteristics of patients with fever of unknown origin in two Colombian pediatric rheumatology centers from 2010 to 2013
- Open Access
- Poster presentation
RM Eraso, MP Velez, F Montoya, J Sierra
PReS-FINAL-2274: Antiadalimumab antibodies in pediatric rheumatology patients. A pilot experience
- Open Access
- Poster presentation
S Murias Loza, RM Alcobendas Rueda, A Remesal Camba, D Pascual Salcedo, J Peralta, R Merino Muñoz
PReS-FINAL-2275: Improvement of calcinosis cutis with intravenous pamidronate in a 2-year-old girl with progressive widespread skin calcification of unknown origin
- Open Access
- Poster presentation
S Mrusek, A Jeibmann, E Lausch, G Ganser
PReS-FINAL-2276: IgG4 related disease in a 10-year-old girl
- Open Access
- Poster presentation
S Pasic, G Ristic, S Djuricic
PReS-FINAL-2277: Clubbing fingers in a boy with arthritis
- Open Access
- Poster presentation
T Giani, G Vannucci, M Davide, E Marrani, A Paladini, G Simonini, I Pagnini, R Cimaz
PReS-FINAL-2278: Description of a Colombian cohort of patients with childhood systemic lupus erytematosus
- Open Access
- Poster presentation
AS Diaz Maldonado, A Monje Gaitan, F Gonzalez, N Gamba
PReS-FINAL-2279: Lupus nephritis in a Colombian cohort of pediatric patients
- Open Access
- Poster presentation
AS Diaz Maldonado, F Gonzalez, A Monje Gaitan, N Gamba
PReS-FINAL-2280: Lupus disease activity in a pediatric Colombian cohort with systemic lupus erytematosus
- Open Access
- Poster presentation
AS Diaz Maldonado, A Monje Gaitan, N Gamba, F Gonzalez
PReS-FINAL-2281: The incidence of antiphospholipid antibodies in children with juvenile onset lupus erythematosus treated in Department of Pediatric Rheumatology, Institute of Rheumatology, Warsaw in the years 2002-2012
- Open Access
- Poster presentation
A Gazda, B Kołodziejczyk, M Wierzbowska, P Gietka, I Szczygielska, L Rutkowska-Sak, J Ząbek, B Wojciechowska, A Kraska
PReS-FINAL-2282: Amaurosis as a presenting sign of antiphospholipid syndrome secondary to systemic lupus erythematosus - case report
- Open Access
- Poster presentation
A Omerčahić-Dizdarević, S Mesihović-Dinarević, V Selmanovic (Mulaosmanovic), A Čengić
PReS-FINAL-2283: Systemic lupus erythematosus (SLE) in children and adolescents in pediatric unite, institute of rheumatology Belgrade, Serbia
- Open Access
- Poster presentation
B Stanimirovic, G Susic, D Novakovic, R Stojanovic
PReS-FINAL-2284: SLE and complement deficiencies: a French multicentric retrospective study
- Open Access
- Poster presentation
B Roland-Gosselin, E Allain-Launay, E Plouvier, L Mouthon, AL Fauchais, JC Lega, H Remeaux, P Cochat, M Desjonquères, M -H Said-Menthon, B Bader-Meunier, A Belot
PReS-FINAL-2285: Pediatric non-renal SLE presenting as periorbital edema: response to treatment with belimumab
- Open Access
- Poster presentation
B Arabshahi
PReS-FINAL-2286: Mastitis in an adolescent patient with juvenile systemic lupus erythematous
- Open Access
- Poster presentation
BE Bica, LMR Saldarriaga, ACP Rocha
PReS-FINAL-2287: Electroconvulsive therapy in a patient with juvenile systemic lupus erythematous
- Open Access
- Poster presentation
BE Bica, LMS Rivera, AN Nicol, GS Campos
PReS-FINAL-2288: Juvenile primary and secondary antiphospolipid syndrome. Clinical and serological features on a Colombian cohort
- Open Access
- Poster presentation
C Malagon, AC Mosquera, MDP Gomez, C Vargas
PReS-FINAL-2289: Ovarian dysfunction in adult childhood-onset lupus patients: a possible role of methotrexate?
- Open Access
- Poster presentation
DB Araujo, LY Yamakami, E Bonfá, VS Viana, SG Pasoto, RM Pereira, PC Serafin, EF Borba, CA Silva
PReS-FINAL-2290: Is an abnormal lipid profile at diagnosis related to increased disease activity in JSLE patients
- Open Access
- Poster presentation
C Thorbinson, L Watson, C Roberts, MW Beresford
PReS-FINAL-2291: Activation of TLR pathway JSLE derived neutrophil extracellular traps
- Open Access
- Poster presentation
C Thorbinson, A Midgley, MW Beresford
PReS-FINAL-2292: Hypogonadism and osteoporosis among adolescents with systemic lupus erythematosus
- Open Access
- Poster presentation
D El-Ghoneimy, K Awwaad, E El-Hadidy, A Abdel-Latif
PReS-FINAL-2293: An attempt to analyze variants of systemic lupus erythematosus onsets in childhood
- Open Access
- Poster presentation
E Kuchinskaya, M Dubko
PReS-FINAL-2294: Juvenile systemic lupus erythematosus in ethnically homogeneous population: a single-centre experience
- Open Access
- Poster presentation
H Malcova, D Nemcova, J Hoza, P Dolezalova
PReS-FINAL-2295: Correlations of health related quality of life reports completed by children with lupus and parents
- Open Access
- Poster presentation
LN Moorthy, E Roy, MG Peterson, AL Hassett, R Cuttica, C Magalhaes, J Sato, S Appenzeller, R Marini, C Len, M Vasco, S Oliveira, M Rodrigues, R Almeida, F Sztajnbok, L Campos, A Jesus, C Silva, E Faugier, L Cobian, A Quintero-Del-Rio, A Adams, L Barinstein, E Chalom, K Onel, J Lopez-Benitez, L Ray, K Haines, P Hashkes, V Cartwright, D Kingsbury, N Singer, I Tomanova-Soltys, S Hong, A Reiff, T Lehman
PReS-FINAL-2296: Thrombocytopenia as a unique manifestation of antiphospholipid syndrome: a case report in the pediatric age
- Open Access
- Poster presentation
LR Campos, F Sztajnbok
PReS-FINAL-2297: Atmospheric pollution: influence on disease activity in childhood-onset systemic lupus erythematosus patients
- Open Access
- Poster presentation
LM Campos, EGC Fernandes, CA Silva, AA Braga, AM Sallum, SCL Farhat
PReS-FINAL-2298: Biometrics of spleen and liver in patients with childhood-onset systemic lupus erythematosus
- Open Access
- Poster presentation
LM Campos, MF Silva, PF Tassetano, AG Alves, SM Rocha, M Valente, CA Silva
PReS-FINAL-2299: Novel biomarkers for the assessment of pediatric systemic lupus erythematosus nephritis (preliminary report)
- Open Access
- Poster presentation
A Koutsonikoli, M Trachana, V Tzimouli, E Farmaki, N Printza, A Garyfallos, V Galanopoulou, P Pratsidou-Gertsi, F Papachristou, F Kanakoudi-Tsakalidou
PReS-FINAL-2300: Shrinking lung syndrome in an adolescent male with juvenile systemic lupus erythematosus
- Open Access
- Poster presentation
M Rodrigues, A Teixeira, C Ferraz, I Brito
PReS-FINAL-2301: Cardiac tamponade and auto-immune haemolysis as first presentation of JSLE
- Open Access
- Poster presentation
M Yiallourides, J Shipman, S Rangaraj
PReS-FINAL-2302: Evaluation of magnetic resonance imaging abnormalities in juvenile neuro-psychiatric systemic lupus erythematosus
- Open Access
- Poster presentation
MRA Al-Obaidi, S Brown, L Ramsden, N Martin, D Saunders, C Pilkington, P Brogan, D Eleftheriou
PReS-FINAL-2303: Exploring potential differences in demographics, family history and disease characteristics in JSLE patients with different age of onset
- Open Access
- Poster presentation
N Groot, AM Midgley, L Watson, C Roberts, MW Beresford
PReS-FINAL-2304: Systemic lupus erythematosus in childhood: experience of single center (data of last ten years)
- Open Access
- Poster presentation
O Kasapcopur, S Sahin, K Barut, N Canpolat, S Caliskan, L Sever, N Arisoy
PReS-FINAL-2305: Erythema multiforme in a child with lupus - what's in a name?
- Open Access
- Poster presentation
R Khubchandani, AD Dhanrajani, DA Parikh
PReS-FINAL-2306: Molecular analysis of HLA-DRB1 alleles in Iranian children with juvenile systemic lupus erythematosus
- Open Access
- Poster presentation
R Shiari, S Farivar, M Dehghan Tezerjani
PReS-FINAL-2307: Libman-Sacks endocarditis as a presentation for systemic lupus erythematous in an adolescent with isolated mitrial regurgitation and Noonan syndrome
- Open Access
- Poster presentation
SC Chen, B Smith, M Ilina, C Bowen, N Martin
PReS-FINAL-2308: Catatonia due to systemic lupus erythematosus: characteristics and 36 months follow up of this rare manifestation of disease
- Open Access
- Poster presentation
V Selmanovic (Mulaosmanovic), T Avčin, S Mesihović-Dinarević, A Omerčahić-Dizdarević, L Oruč, S Zubčević, D Miličić-Pokrajac, D Anić, A Mornjaković-Franca, S Tanović, A Bučan-Varatanović, A Čengić
PReS-FINAL-2309: Juvenile systemic lupus erythematosus: a case series depiction in an urban community and a comparison to an adult case series
- Open Access
- Poster presentation
V Torrente-Segarra, E Iglesias, MI Gonzalez, J Sanchez, S Ricart, R Bou, T Salman-Monte, J Carbonell, J Antón-López
PReS-FINAL-2310: Successful rituximab treatment in a 14 year-old boy with lupus nephritis
- Open Access
- Poster presentation
V Torrente-Segarra, E Iglesias, R Bou, S Ricart, MI Gonzalez, J Sanchez, L Lopez-Vives, J Antón-López
PReS-FINAL-2311: Rituximab in paediatric ANCA-associated vasculitis
- Open Access
- Poster presentation
G Mestrallet, A Faye, P Quartier, B Ranchin, P Cochat, A Belot
PReS-FINAL-2312: Cogan's syndrome: a diagnostic challenge. Report and review of the literature
- Open Access
- Poster presentation
A Lazareva, ZD Davidsone, R Santere, S Kuske, V Stanevicha
PReS-FINAL-2313: Clinical experiences of therapy in pediatric patients with Behcet uveitis, singe center study
- Open Access
- Poster presentation
B Sozeri, S Yilmaz, S Mir, H Ates
PReS-FINAL-2314: Anti-TNF alpha therapy for refractory childhood takayasu arthritis
- Open Access
- Poster presentation
B Koren, Š Blazina, N Toplak, D Ključevšek, T Avčin
PReS-FINAL-2315: Severe cutaneous vasculitis in two patients with juvenile idiopathic arthritis and biologic therapy
- Open Access
- Poster presentation
F Falcini, G Lepri, G Carnesecchi, F Bertini, M Matucci Cerinic
PReS-FINAL-2316: Churg-Strauss syndrome in a 17-year-old girl
- Open Access
- Poster presentation
G Ristic
PReS-FINAL-2317: Clinical presentation, management and outcome of Kawasaki disease (4 years reviews)
- Open Access
- Poster presentation
HM Benamer, Halima M Benamer, Brika Brwag
PReS-FINAL-2318: The structural and functional changes of biomembrains of FMF and HSP with children
- Open Access
- Poster presentation
H Sargsyan, P Ghazaryan
PReS-FINAL-2319: PED-BD cohort 2013: expert consensus classification gives higher sensitivity than the international study group criteria to define Behcet's disease in children
- Open Access
- Poster presentation
I Koné-Paut, M Darce Bello, F Shahram, S Ozen, R Cimaz, H Michael, M Gattorno, B Chkirate, K Bouayed, L Cantarini, J Anton, I Tugal-Tuktun, J Kummerle-Deschner, A Faye, S Benamour, TA Tran, A Arnoux
PReS-FINAL-2320: Different clinical presentation of takayasu arthritis: case report of two pediatric patients
- Open Access
- Poster presentation
I Rukavina, I Malčić, M Frković, M Jelušić
PReS-FINAL-2321: Clinical manifestations of granulomatosis with polyangiitis in 8 children from south-east region of Poland
- Open Access
- Poster presentation
J Kosałka, M Ignacak, A Zugaj, S Bazan-Socha, K Zachwieja, I Głodzik, G Lis, Z Żuber, J Musiał
PReS-FINAL-2322: Outcome of kidney transplantation in paediatric patients with ANCA associated glomerulonephritis: a single-center experience
- Open Access
- Poster presentation
M Twilt, D Noone, W Hayes, P Thorner, S Benseler, R Parekh, R Laxer, D Hebert
PReS-FINAL-2323: Cryoglobulinemic vasculitis preceding diagnosis of Carney complex
- Open Access
- Poster presentation
MB Glerup, C Heuck, J Bjerre, T Herlin
PReS-FINAL-2324: PAPA syndrome clinical spectrum and IL-1Β release
- Open Access
- Poster presentation
A Omenetti, R Caorsi, S Carta, L Delfino, F Penco, C Pastorino, F Schena, A Martini, A Rubartelli, M Gattorno
PReS-FINAL-2325: Different phenotypes associated with Q703K variant of the NLRP3 gene
- Open Access
- Poster presentation
A Von Scheven-Gête, M Hofer, G Simon, N Busso, M Morris, F Vanoni
PReS-FINAL-2326: No correlation between anti-drug antibodies and pharmacokinetics, efficacy or safety of Anakinra (Kineret®) in patients with severe CAPS
- Open Access
- Poster presentation
M Wikén, P Gozzi, G Andersson, H Olivecrona, M Aldén Raboisson, T Kullenberg, M Leinonen, B Hallén
PReS-FINAL-2327: Abatacept in the treatment of refractory uveitis
- Open Access
- Poster presentation
D Moretti, T Giani, G Vannucci, E Marrani, G Simonini, I Pagnini, R Cimaz
PReS-FINAL-2328: Developing and validating the new severity score for FMF
- Open Access
- Poster presentation
E Demirkaya, C Acikel, A Gul, M Gattorno, E Ben-Chetrit, H Ozdogan, P Hashkes, A Polat, A Livneh, S Ozen
PReS-FINAL-2329: Validation of the autoinflammatory activity index (AIDAI)
- Open Access
- Poster presentation
M Piram, I Kone-Paut, H Lachmann, S Ozen, J Kuemmerle-Deschner, S Stojanov, A Simon, M Finetti, MP Sormani, A Martini, M Gattorno, N Ruperto
PReS-FINAL-2330: Canakinumab treatment in patients with HIDS
- Open Access
- Poster presentation
J Antón, I Calvo, A Robles, J Yagüe, J Aróstegui, R Viana, S Bhansali, K Abrams
PReS-FINAL-2331: Low-penetrance NLRP3 variants
- Open Access
- Poster presentation
T Endres, F Hofer, R Goldbach-Mansky, HM Hoffman, N Blank, K Krause, C Rietschel, G Horneff, P Lohse, J Kuemmerle-Deschner
PReS-FINAL-2332: Activation-induced cell death of human monocytes as a novel mechanism fine-tuning inflammation and autoimmunity
- Open Access
- Poster presentation
M Miranda-García, J Däbritz, G Varga, T Weinhage, J Ehrchen, K Barczyk, J Roth, D Foell
PReS-FINAL-2333: Long term efficacy of interleukin-1 receptor antagonist (anakinra) in a multicentric cohort of patients affected by idiopathic recurrent pericarditis
- Open Access
- Poster presentation
M Finetti, A Insalaco, L Cantarini, M D'Alessandro, A Meini, L Breda, M Alessio, P Picco, A Martini, M Gattorno
PReS-FINAL-2334: Chronic recurrent multifocal osteomyelitis and tnf-αlfa inhibitors
- Open Access
- Poster presentation
M Alberdi-Saugstrup, SM Nielsen
PReS-FINAL-2335: Preliminary analysis of 85 patients with mevalonate kinase deficiency from the eurofever registry
- Open Access
- Poster presentation
N Ter Haar, H Lachmann, P Woo, A Simon, A Meini, P Dolezalova, C Modesto, S Stojanov, B Bader-Meunier, A Insalaco, E Hoppenreijs, E Gallo, N Ruperto, J Frenkel, M Gattorno
PReS-FINAL-2336: Induction of MDSCS in Muckle-Wells syndrome
- Open Access
- Poster presentation
N Rieber, A Brand, D Neri, T Hall, I Schäfer, S Hansmann, J Kümmerle-Deschner, D Hartl
PReS-FINAL-2337: The eurofever registry: 3 years of enrollment
- Open Access
- Poster presentation
S Federici, J Frenkel, S Ozen, J Antòn, JI Arostegui, F De Benedetti, P Dolezalova, H Girschick, V Hentgen, M Hofer, H Lachmann, I Koné-Paut, J Kuemmerle-Deschner, B Neven, H Ozdogan, C Rose, A Simon, S Stojanov, N Toplak, I Touitou, R Vesely, P Woo, C Wouters, N Ruperto, A Martini, M Gattorno
PReS-FINAL-2338: Fate of lymphocytes after withdrawal of Tofacitinib treatment
- Open Access
- Poster presentation
A Tommasini, E Piscianz, E Valencic, E Cuzzoni, G Decorti, A Taddio
PReS-FINAL-2339: Blocking interferon alpha signaling can reduce neutrophil extracellular trap formation in juvenile onset systemic lupus erythematosus
- Open Access
- Poster presentation
A Midgley, MW Beresford
PReS-FINAL-2340: A pathogenic role for S100A8/A9 in experimental autoimmune arthritis
- Open Access
- Poster presentation
C Kessel, J Roth, D Foell, T Vogl
PReS-FINAL-2341: Perturbed homeostasis of FOXP3+ regulatory T cells and STAT1 signaling in SLE patients with childhood and adult onset of disease
- Open Access
- Poster presentation
M Holcar, A Goropevšek, N Semolič, A Pahor, T Avčin
PReS-FINAL-2342: Anti-TNFALPHA therapy targeys PKB/C-AKT induced resistance of effector cells to suppression in juvenile arthritis
- Open Access
- Poster presentation
E Wehrens, S Vastert, G Mijnheer, J Meerding, M Klein, N Wulffraat, B Prakken, F van Wijk
PReS-FINAL-2343: Cartilage thickness of the knee in juvenile idiopathic arthritis. comparative assessment by ultrasonography and magnetic resonance imaging
- Open Access
- Poster presentation
D Pradsgaard, B Fiirgaard, AH Spannow, CW Heuck, T Herlin
PReS-FINAL-2344: Radiographic evaluation of joint space width compared to cartilage thickness as assessed by ultrasonography in knees of children with juvenile idiopathic arthritis
- Open Access
- Poster presentation
D Pradsgaard, A Hørlyck, AH Spannow, CW Heuck, T Herlin
PReS-FINAL-2345: Frequency of radiographic damage and progression in individual joints in children with juvenile idiopathic arthritis
- Open Access
- Poster presentation
G Giancane, S Pederzoli, X Norambuena, M Ioseliani, J Sato, MC Gallo, G Negro, N Ruperto, A Martini, A Ravelli
PReS-FINAL-2346: Hypomorphic RAG deficiencies: phenotypic variability and usefulness of TREC/KREC as diagnostic biomarkers
- Open Access
- Poster presentation
C Schuetz, U Pannicke, EM Jacobsen, M Honig, T Niehues, K Schwarz, AS Schulz
PReS-FINAL-2347: Does switching anti-TNFΑ biologic agents an effective option in childhood chronic uveitis: the evidence from a systematic review and meta-analysis approach
- Open Access
- Poster presentation
G Simonini, K Druce, R Cimaz, GT Jones, GT Macfarlane
PReS-FINAL-2348: Identification of autoantibodies against inner ear antigens in a cohort of children with idiopathic sensorineural hearing loss
- Open Access
- Poster presentation
G Vannucci, E Berti, G Simonini, C Lunardi, C Bason, T Giani, I Pagnini, D Moretti, E Marrani, R Cimaz
PReS-FINAL-2349: Spectrum of thrombotic and non-thrombotic manifestations in 159 children with positive antiphospholipid antibodies
- Open Access
- Poster presentation
M Rozic, A Trampus-Bakija, Z Rener-Primec, L Kitanovski, T Kveder, T Avcin
PReS-FINAL-2350: Overexpression of crem alpha leads to a higher inflammatory response in lps induced acute lung injury (ali) and might therefore trigger infectious complications in patients with autoimmune diseases
- Open Access
- Poster presentation
E Verjans, A Wiener, K Ohl, N Wagner, S Uhlig, C Martin, K Tenbrock
PReS-FINAL-2351: Children with probable SLE by ACR criteria may need more aggressive lupus treatment early in the disease course
- Open Access
- Poster presentation
A Patwardhan, I Dvorchik, C Spencer
PReS-FINAL-2352: Apoptosis profile in patients with juvenile-onset systemic lupus erythematosus
- Open Access
- Poster presentation
B Liphaus, MH Kiss, S Carrasco, C Goldenstein-Schainberg
PReS-FINAL-2353: Are rasopathies new monogenic predisposing conditions to the development of systemic lupus erythematosus?
- Open Access
- Poster presentation
B Bader-Meunier, H cave, N jeremiah, F Rieux-Laucat
PReS-FINAL-2354: Laboratory investigation of the role of toll-like receptros on kidney cells in pathogenesis of lupus nephritis
- Open Access
- Poster presentation
E Sen, G Welsh, A Ramanan, M Saleem
PReS-FINAL-2355: Comparison of pediatric and adult SLE genetic load
- Open Access
- Poster presentation
MD Dominguez, ED Silverman, J Beyene
PReS-FINAL-2356: A comparison of the American college of rheumatology and the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus using data from the uk juvenile systemic lupus erythematosus cohort study
- Open Access
- Poster presentation
O Lloyd, E Heaf, T Morgan, C Roberts, L McCann, MW Beresford
PReS-FINAL-2357: Effects of anti-melanocyte stimulating hormone in murine pristine-induced lupus
- Open Access
- Poster presentation
T Peixoto, S Mello, D Botte, S Carrasco, M Vendramini, C Goldenstein-Schainberg
PReS-FINAL-2358: T helper cells in henoch-schönlein purpura/iga vasculitis
- Open Access
- Poster presentation
B Gülhan, D Orhan, E Karabulut, F Özaltın, R Topaloğlu, A Düzova, S Özen
PReS-FINAL-2359: Renal involvement in hypocomplementemic urticarial vasculitis syndrome (huvs): report of 3 paediatric cases
- Open Access
- Poster presentation
C Bracaglia, A Aceti, M Vivarelli, A Insalaco, M Pardeo, R Nicolai, F De Benedetti, A Pasini
PReS-FINAL-2360: Severe disease course of pediatric-onset granulomatosis with polyangiitis as compared to adult patients: a long-term, single center, follow up study
- Open Access
- Poster presentation
G Minardo, V Carraro, G Martini, L Murer, F Vittadello, F Schiavon, F Zulian
PReS-FINAL-2361: Maintenance treatment in childhood granulomatosis with polyangiitis
- Open Access
- Poster presentation
M Twilt, R Schneider, D hebert, E harvey, R laxer, S dell, C licht, S benseler
PReS-FINAL-2362: The spectrum of childhood inflammatory brain diseases; an increasingly recognised field
- Open Access
- Poster presentation
M Twilt, S Sheikh, S Benseler
PReS-FINAL-2363: Behçet's disease in children: the Great Ormond Street Hospital experience
- Open Access
- Poster presentation
S Nanthapisal, D Eleftheriou, Y Hong, N Klein, PA Brogan
PReS-FINAL-2364: Status epilepticus as an initial manifestation of central nervous system small vessel vasculitis is related to unfavourable neurological outcome in paediatric patients
- Open Access
- Poster presentation
V Krakovská, M Twilt, S Sheikh, P Doležalová, SM Benseler
PReS13-SPK-1253: Challenges in nursing care with the new biologics for JIA
- Open Access
- Invited speaker presentation
P Livermore
PReS13-SPK-1034: looking for new monogenic forms of lupus
- Open Access
- Invited speaker presentation
Y Crow
PReS13-SPK-1283: Pathogenesis, diagnosis and management of neuropsychiatric SLE
- Open Access
- Invited speaker presentation
D Boumpas
PReS13-SPK-1137: New developments in our care & understanding of JIA
- Open Access
- Invited speaker presentation
MW Beresford
PReS13-SPK-1590: Relevance of cytokine in pediatric inflammatory disease
- Open Access
- Invited speaker presentation
F De Benedetti
PReS13-SPK-1472: Science of muscle training in inflammatory disease
- Open Access
- Invited speaker presentation
M Van Brussel
PReS13-SPK-1592: Pediatric aspects of antiphospholipid syndrome
- Open Access
- Invited speaker presentation
T Avcin
PReS13-SPK-1322: Autoinflammatory in nature: what patients teach us
- Open Access
- Invited speaker presentation
M Gattorno
PReS13-SPK-1182: Six years of eu paediatric regulation - what was achieved for paediatric rheumatology
- Open Access
- Invited speaker presentation
R Vesely
PReS13-SPK-1408: New EU scientific guidelines for JIA, SLE and GIOP from the European Medicines Agency
- Open Access
- Invited speaker presentation
R Vesely
PReS13-SPK-1587: New biologic targets for the future and basic science behind them
- Open Access
- Invited speaker presentation
B Prakken
PReS13-SPK-1332: Assessment of disease activity and damage in juvenile idiopathic arthritis
- Open Access
- Invited speaker presentation
A Ravelli
PReS13-SPK-1028: Activity and damage - we have to measure them
- Open Access
- Invited speaker presentation
H Brunner
PReS13-SPK-1582: Activity and damage - we have to measure them
- Open Access
- Invited speaker presentation
BM Feldman
PReS13-SPK-1247: Activity and damage in juvenile systemic sclerosis- we have to measure them
- Open Access
- Invited speaker presentation
I Foeldvari
PReS13-SPK-1586: Biological agents for the treatment of rheumatic diseases: present and future targets of biologic therapy
- Open Access
- Invited speaker presentation
I Mcinnes
PReS13-SPK-1579: Biologic agents for the treatment of rheumatic diseases
- Open Access
- Invited speaker presentation
P Emery
PReS13-SPK-1577: 'Asia' - autoimmune (auto-inflammatory) syndromes induced by adjuvants
- Open Access
- Invited speaker presentation
YY Shoenfeld
PReS13-SPK-1350: Autoimmune responses following vaccination in healthy populations
- Open Access
- Invited speaker presentation
N Toplak
PReS13-SPK-1212: Vaccination in paediatric patients with auto-immune and autoinflammatory diseases
- Open Access
- Invited speaker presentation
N Wulfraat
PReS13-SPK-1321: Expanding clinical spectrum of autoinflammatory diseases
- Open Access
- Invited speaker presentation
I Aksentijevich
PReS13-SPK-1107: Development of an academic pediatric rheumatology program
- Open Access
- Invited speaker presentation
R Laxer
PReS13-SPK-1127: Pediatric rheumatology in India
- Open Access
- Invited speaker presentation
RP Khubchandani
PReS13-SPK-1572: The therapy management of pain amplification syndrome
- Open Access
- Invited speaker presentation
S Maillard
PReS-FINAL-1001: Lymphocytes from the inflamed joint of juvenile idiopathic arthritis patients express reduced levels of cd73 and have a functional defect in adenosine production
- Open Access
- Oral presentation
S Botta Gordon-Smith, S Eaton, S Ursu, H Moncrieffe, LR Wedderburn
PReS-FINAL-1002: Dissecting the dissociation of foxp3 and cd25 expression on cd4+ t cells in synovial fluid identifies three distinct subpopulations of human t regulatory cells present at the chronically inflamed site
- Open Access
- Oral presentation
D Bending, AM Pesenacker, Q Wu, LR Wedderburn
PReS-FINAL-1020: Dysregulation of the peripheral blood D cell compartment is associated with disease activity in juvenile dermatomyositis
- Open Access
- Oral presentation
C Piper, H Varsani, K Arnold, L Wedderburn, C Mauri, K Nistala
PReS-FINAL-2001: The impact of adalimumab on growth in patients with juvenile idiopathic arthritis
- Open Access
- Oral presentation
N Ruperto, DJ Lovell, K Jarosova, D Nemcova, V Vargová, H Michels, EC Chalom, N Ilowite, C Wouters, HI Brunner, KK Kracht, H Kupper, E Giannini, A Martini, N Mozaffarian
PReS-FINAL-2002: Adverse events during anti-TNF therapy in patients with JIA
- Open Access
- Oral presentation
M Tarkiainen, P Tynjälä, P Vähäsalo, P Lahdenne
PReS-FINAL-2003: Remission and predictors of persistent disease activity at 30 years follow-up in a Norwegian cohort of juvenile idiopathic arthritis patients
- Open Access
- Oral presentation
AM Selvaag, HA Aulie, V Lilleby, B Flatø
PReS-FINAL-2004: Musculoskeletal pain in schoolchildren across puberty: a 3-year follow-up study
- Open Access
- Oral presentation
F Sperotto, S Brachi, G Cuffaro, M Seguso, F Vittadello, F Zulian
PReS-FINAL-2173: Protein kinase C delta deficiency is a new cause of monogenic SLE
- Open Access
- Oral presentation
A Belot, PK Kasher, EW Trotter, AP Foray, AL Debaud, E Meffre, J Brognard, N Bonnefoy, Y Crow
PReS-FINAL-2174: The performance of the new slicc criteria for the classification of sle in children
- Open Access
- Oral presentation
E Sag, A Ravelli, ED Batu, A Tartaglione, AS Khalil, S Marks, S Ozen
PReS-FINAL-2175: Pharmacokinetics of mycophenolate mofetil in children with lupus and clinical findings in favour of therapeutic drug monitoring
- Open Access
- Oral presentation
JB Woillard, B Bader-Meunier, R Salomon, B Ranchin, S Decramer, M Fischbach, E Berard, F Saint-Marcoux
PReS-FINAL-2176: Declines in levels of disease activity and physical disability in children with juvenile idiopathic arthritis seen in standard clinical care over the last 25 years
- Open Access
- Oral presentation
A Consolaro, S Lanni, F Minoia, S Davì, S Dalprà, B Schiappapietra, V Muratore, A Martini, A Ravelli
PReS-FINAL-2177: Safety and lack of autoantibody production following influenza H1N1 vaccination in patients with juvenile idiopathic arthritis (JIA)
- Open Access
- Oral presentation
N Aikawa, C Goldenstein-Schainberg, M Vendramini, L Campos, C Saad, J Moraes, A Duarte, A Precioso, M Timenesky, E Bonfa, C Silva
PReS-FINAL-2178: Clinical and microarray follow-up of SJIA patients treated with anakinra over the past 10 years in a single institution
- Open Access
- Oral presentation
M Punaro, A Gotte, M Stoll, D Blankenship, F Allantaz, Z Xu, V Pascual
PReS-FINAL-2179: Efficacy and safety of adalimumab in pediatric patients with enthesitis related arthritis
- Open Access
- Oral presentation
R Burgos-Vargas, S Tse, G Horneff, AL Pangan, K Unnebrink, JK Anderson
PReS-FINAL-2180: Efficacy and safety of tocilizumab (TCZ) in patients with polyarticular-course juvenile idiopathic arthritis (pcJIA): 2-year data from CHERISH
- Open Access
- Oral presentation
F De Benedetti, N Ruperto, Z Zuber, R Cuttica, R Xavier, I Calvo, N Rubio, E Alekseeva, V Chasnyk, J Chavez, G Horneff, V Opoka-Winiarska, P Quartier, A Spindler, C Keane, K Bharucha, J Wang, D Lovell, A Martini, HI Brunner
PReS-FINAL-2181: Recombinant il-1ra restores the il-18-nk cell axis in steroid naive systemic juvenile idiopathic arthritis
- Open Access
- Oral presentation
W De Jager, SJ Vastert, G Mijnheer, BJ Prakken, NM Wulffraat
PReS-FINAL-2182: The role of murine rage in innate immune responses and inflammation: a systematic approach
- Open Access
- Oral presentation
T Wirth, C Kessel, T Weinhage, P Becker, N Nippe, D Foell
PReS-FINAL-2183: IL-6 amplifies toll like receptor mediated cytokine and chemokine production: implications for the pathogenesis of rheumatic inflammatory diseases
- Open Access
- Oral presentation
I Caiello, G Minnone, D Holzinger, T Vogl, F De Benedetti, R Strippoli
PReS-FINAL-2184: A randomized trial in new onset juvenile dermatomyositis: prednisone versus prednisone plus cyclosporine versus prednisone plus methotrexate
- Open Access
- Oral presentation
N Ruperto, A Pistorio, S Knupp Feitosa de Oliveira, R Cuttica, A Ravelli, M Fischbach, B Magnusson, T Avcin, K Brochard, F Corona, G Couillault, F Dressler, V Gerloni, G Sterba, F Zulian, MT Apaz, A Cespedes-Cruz, R Cimaz, C Bracaglia, R Joos, P Quartier, R Russo, M Tardieu, N Wulffraat, S Angioloni, A Martini
PReS-FINAL-2185: Prognostic markers in juvenile vs. adult-onset ankylosing spondylitis
- Open Access
- Oral presentation
D Jadon, LP Hunt, R Arumugam, AV Ramanan, R Sengupta
PReS-FINAL-2186: Monoallelic mutations of familial hlh-related genes associated to macrophage activation syndrome
- Open Access
- Oral presentation
C Bracaglia, E Sieni, V Cetica, M Da Ros, A Insalaco, C De Fusco, C Micalizzi, F De Benedetti, M Aricò
PReS-FINAL-2187: Use of screening tests in patients presenting to paediatric rheumatology with suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome
- Open Access
- Oral presentation
M Cruikshank, P Anoop, O Nikolajeva, A Rao, K Rao, K Gilmour, D Eleftheriou, PA Brogan
PReS-FINAL-2188: Insulin sensitivity is improved in sjia children with insulin resistance after tocilizumab treatment: results from the tender study
- Open Access
- Oral presentation
H Mirjafari, N Ruperto, HI Brunner, Z Zuber, F Zulian, MR Maldonado-Velázquez, E Mantzourani, K Murray, J Roth, J Rovensky, O Vougiouka, J Wang, O Harari, D Lovell, A Martini, F De Benedetti
PReS-FINAL-2189: Tocillizumab for patients with takayasu arteritis in childhood refractory to conventional therapy
- Open Access
- Poster presentation
K Yamazaki, M Kikuchi, T Nozawa, T Kanetaka, R Hara, T Imagawa, K Nishimura, N Sakurai, T Sato, S Yokota
PReS-FINAL-2190: Validation of the new histopathological classification of anca glomerulonephritis and its association with renal outcomes in a paediatric population
- Open Access
- Oral presentation
M Twilt, D Noone, W Hayes, P Thorner, S Benseler, R Parekh, R Laxer, D Hebert
PReS-FINAL-2191: Imaging of chronic recurrent multifocal osteitis: a french national cohort of 178 cases
- Open Access
- Oral presentation
J Wipff, D Nouar, I Lemelle, C Pajot, A Duquesne, M Lorrot, A Faye, B Bader-Meunier, K Brochard, V Despert, S Jean, M Grall-Lerosey, Y Marot, A Pagnier, P Quartier, C Deslandre
PReS-FINAL-2192: Late cardiac assessment in children who were diagnosed with post streptococcal reactive arthritis - a long term study
- Open Access
- Oral presentation
Y Uziel, Y Kwint, A Matitiahu, A Levi, L Pearl, J Barash
PReS-FINAL-2193: Assessment of construct validity of new measures of global disease activity, physical function and quality of life in children with juvenile dermatomyositis
- Open Access
- Oral presentation
C Ferrari, GC Varnier, A Consolaro, D Marafon, C Pilkington, S Maillard, M Jelusic-Drazic, A Civino, A Martini, A Ravelli
PReS-FINAL-2194: Evidence-based clinical classification criteria for periodic fevers
- Open Access
- Oral presentation
S Federici, S Ozen, I Koné-Paut, H Lachmann, P Woo, L Cantarini, G Amaryan, A Insalaco, J Kuemmerle-Deschner, B Neven, N Dewarrat, Y Uziel, D Rigante, T Herlin, S Martino, A Simon, S Stojanov, H Ozdogan, J Frenkel, N Ruperto, A Martini, MP Sormani, M Hofer, M Gattorno
PReS-FINAL-2365: Southern hemisphere educational partnership for pediatric arthritis and rheumatological diseases (Sheppard): pediatric rheumatology without borders
- Open Access
- Poster presentation
RA Russo, MM Katsicas, K Webb, C Scott
PReS-FINAL-2367: Academic training of pediatric rheumatologist in the Russian federation
- Open Access
- Oral presentation
E Alekseeva, E Chistyakova
PReS-FINAL-2368: A, B, C, don't ever forget the joints
- Open Access
- Oral presentation
W Abusrewil, A Whiteley, A-M McMahon, M Al-Obaidi
PReS-FINAL-1003: Intrinsic cd4 and cd8 effector t cell resistance to suppression in the synovial fluid of juvenile idiopathic arthritis patients
- Open Access
- Poster presentation
A Petrelli, EJ Wehrens, BJ Prakken, F van Wijk
PReS-FINAL-1013: Magnetic resonance imaging as a non-invasive tool to assess muscle edema in juvenile dermatomyositis. Return to normal after treatment
- Open Access
- Poster presentation
E Iglesias, M Navallas, L Riaza, V Torrente-Segarra, R Bou, S Ricart, MI González, J Sánchez, J Antón
PReS-FINAL-1014: Role of MHC class I overexpression on muscle biopsy of patients with juvenile dermatomyositis
- Open Access
- Poster presentation
J Sanchez-Manubens, E Iglesias, C Jou, MI Gonzalez, R Bou, V Torrente-Segarra, S Ricart, J Calzada-Hernandez, J Anton
PReS-FINAL-1015: A systematic literature review on diagnosis and treatment of pediatric rheumatic diseases: a shared initiative
- Open Access
- Poster presentation
V Boom, N de Graeff, F Belutti Enders, N Groot, N ter Haar, F Sperotto, S Vastert, N Wulffraat
PReS-FINAL-1016: Micro vesicles as a magnifying glass; uncovering potential biomarkers in juvenile idiopathic arthritis
- Open Access
- Poster presentation
G Keustermans, B Prakken, W de Jager
PReS-FINAL-1017: Antioxidant superoxide dismutase activity is elevated in jia but not associated with disease activity
- Open Access
- Poster presentation
A Radziszewska, C Rowden, L Suffield, S Ursu, L Kassoumeri, LR Wedderburn, Y Ioannou
PReS-FINAL-1018: Can the CD4/CD8β ratio be used as a predictive biomarker in extended-to-be oligoarticular JIA?
- Open Access
- Poster presentation
S De Leeuw, B Thirugnanabalan, H Varsani, F Warden, N Makengo, J Lewis, A Pesenacker, L Wedderburn
PReS-FINAL-1019: Inflammatory monocytes induce resistance of effector t cells to suppression
- Open Access
- Poster presentation
EJ Wehrens, A Boltjes, M Klein, SJ Vastert, BJ Prakken, F Van Wijk
PReS-FINAL-1021: Further characterization of CD161+ regulatory t cells in health and disease
- Open Access
- Poster presentation
CL Duurland, G Chain, RF O'Shaughnessy, AM Pesenacker, LR Wedderburn
PReS-FINAL-2005: Prevalence of antinuclear antibodies in schoolchildren across puberty and possible relationship with musculoskeletal pain. A longitudinal study
- Open Access
- Poster presentation
F Sperotto, S Brachi, M Seguso, F Vittadello, F Zulian
PReS-FINAL-2006: Resilience and coping in adolentes with rheumatic illness
- Open Access
- Poster presentation
M Alessio, F Fontana, A Officioso, S Cotini, F Fontana, C Forni, M Alessio
PReS-FINAL-2088: Risk of severe adverse events in juvenile idiopathic arthritis and pediatric-onset inflammatory bowel disease, treated with anti-tnf drugs
- Open Access
- Poster presentation
P Vatta, A Taddio, L Lepore, V Moressa, S Naviglio, E Prinzi
PReS-FINAL-2089: Temporomandibular joint involvement and quality of life in juvenile idiopathic arthritis
- Open Access
- Poster presentation
P Frid, E Nordal, F Bovis, D Marafon, D De Angelis, S Oliveira, G Simonini, F Corona, J Davidson, H Foster, R Joos, I Foeldvari, M Steenks, P Lahdenne, P Dolezalova, E Palmisani, A Martini, A Pistorio, N Ruperto
PReS-FINAL-2090: Efficacy of anti-TNF drugs from the perspective of growth velocity: a single center experience
- Open Access
- Poster presentation
P Mrážik, V Vargová
PReS-FINAL-2091: Extra-articular calcification after intra-articular corticosteroid injection
- Open Access
- Poster presentation
P Toftedal, LA Bistrup, AE Christensen
PReS-FINAL-2092: Bone marrow cells (BMC) added to platelet-rich plasma (PRP) for treatment of bone degenerative processes in JIA patients: follow-up of 2 cases
- Open Access
- Poster presentation
P Salvati, S Callegari, G Tripodi, MB Michelis, S Boero, R Lorini, MG Alpigiani
PReS-FINAL-2093: Can clinical response within 12 weeks in JIA-etanercept receivers predict the future clinical remission?
- Open Access
- Poster presentation
P Pratsidou-Gertsi, E Verykouki, G Pardalos, M Trachana
PReS-FINAL-2094: Evaluation of the benefits of sequential addition of leflunomide in patients with polyarticular course juvenile idiopathic arthritis failing standard dose methotrexate
- Open Access
- Poster presentation
PR Chickermane, RP Khubchandani
PReS-FINAL-2095: Older age predicts poor response to 6-months methotrexate therapy in a juvenile idiopathic arthritis cohort of patients
- Open Access
- Poster presentation
R Marques, F Ramos, I Perpétuo, S Fernandes, C Furtado, AF Mourão, F Martins, H Canhão, JE Fonseca, JA Pereira da Silva
PReS-FINAL-2096: Herpes virus infections in patients with juvenile idiopathic arthritis (JIA) treated with etanercept
- Open Access
- Poster presentation
R Nicolai, E Cortis, L Ravà, C Bracaglia, M Pardeo, A Insalaco, PS Buonuomo, F De Benedetti, AE Tozzi
PReS-FINAL-2097: Evaluation of gait in children with juvenile idiopathic arthritis
- Open Access
- Poster presentation
SN Baydogan, E Tarakcı, O Kasapcopur
PReS-FINAL-2098: Evaluation of the disease course of Italian children with juvenile idiopathic arthritis treated with etanercept: preliminary results in 313 patients
- Open Access
- Poster presentation
S Verazza, A Consolaro, A Frisina, G Conti, D Rigante, C Robbiano, MG Alpigiani, A Ravelli
PReS-FINAL-2099: Assessing the standards of oral health in children and adolescents with juvenile idiopathic arthritis
- Open Access
- Poster presentation
SJ Trehane, H Strike, A Ramanan
PReS-FINAL-2100: Methotrexate treatment affects effector, but not regulatory T cells in juvenile idiopathic arthritis
- Open Access
- Poster presentation
S Vastert, M Bulatovic-Calasan, R Scholman, M Klein, N Wulffraat, B Prakken, FV Wijk
PReS-FINAL-2101: Nitrous oxide analgesia for intra-articular injection in juvenile idiopathic arthritis: our experience
- Open Access
- Poster presentation
S Pastore, V Moressa, G Gortani, L Lepore
PReS-FINAL-2102: Comparison of sensitivity and specificity of MAS and HLH diagnostic guidelines in 362 children with MAS complicating systemic JIA
- Open Access
- Poster presentation
S Davì, F Minoia, AC Horne, E Demirkaya, N Ilowite, A Insalaco, M Ioseliani, M Jelusic-Drazic, MA Kapovic, O Kasapcopur, I Kone-Paut, L Lepore, C Li, S Magni-Manzoni, D Maritsi, D Mccurdy, R Merino, P Miettunen, N Ruperto, A Martini, RQ Cron, A Ravelli
PReS-FINAL-2103: Real life management of VZV infection or reactivation in rheumatic children on biologics: the French experience
- Open Access
- Poster presentation
S Guillaume-Czitrom, V Remy-Piccolo, A Duquesne, I Kone-Paut, M Grall, E Allain-Launay, R Dagher, A Faye, K Brochard, E Grouteau, C Pietrement, L Rossi, P Quartier, J Morel
PReS-FINAL-2104: Disease course and predictors of outcome in systemic onset juvenile idiopathic arthritis
- Open Access
- Poster presentation
S Soponkanaporn, S Vilaiyuk
PReS-FINAL-2105: Can routine clinical and laboratory data predict JIA diagnosis and disease course in acute arthritis?
- Open Access
- Poster presentation
S Rusoniene, V Panaviene
PReS-FINAL-2106: Clinical psoriatic arthritis of specific children
- Open Access
- Poster presentation
S Chebisheva, A Meleshkina
PReS-FINAL-2107: In vitro investigation into mesenchymal stromal cells as a potential therapeutic in juvenile arthritis
- Open Access
- Poster presentation
J Wienke, S De Roock, J Swart, A Martens, N Wulffraat, B Prakken
PReS-FINAL-2108: Long-term outcome of 114 adult JIA patients in a non-pediatric rheumatology institute in Japan
- Open Access
- Poster presentation
T Miyamae, E Tanaka, T Kishi, T Matsuyama, T Igarashi, S Fujikawa, A Taniguchi, S Momohara, S Nagata, H Yamanaka
PReS-FINAL-2109: Genetic variations in patients with juvenile idiopathic arthritis and uveitis
- Open Access
- Poster presentation
TH Reinards, H Albers, D Brinkman, S Kamphuis, M Van Rossum, E Hoppenreijs, H Girschick, C Wouters, R Saurenmann, R Toes, T Huizinga, J Houwing-Duistermaat, M Schilham, R Ten Cate
PReS-FINAL-2110: Tocilizumab for patients with oligoarticular juvenile idiopathic arthritis refractory to conventional therapy
- Open Access
- Poster presentation
T Sato, K Nishimura, T Nozawa, T Kanetaka, M Kikuchi, R Hara, N Sakurai, K Yamazaki, Y Takeuchi, S Yokota
PReS-FINAL-2111: Cytomegalovirus, Epstein Barr virus and Varicella-Zoster virus infections in children with juvenile idiopathic arthritis treated with biologics
- Open Access
- Poster presentation
V Remy Piccolo, S Sotou-Bere, A Woerner, R Mouy, B Florkin, B Bader-Meunier, P Quartier
PReS-FINAL-2112: Mapping the treatment effect of infliximab on a case of refractory anterior uveitis related to juvenile idiopathic arthritis (JIA)
- Open Access
- Poster presentation
V Miranda, C Zilhão, P Menéres, M Guedes
PReS-FINAL-2113: The association of the NFKB1 gene polymorphism with systemic onset juvenile idiopathic arthritis in Russia
- Open Access
- Poster presentation
VA Malievsky, TV Viktorova, KV Danilko, LS Nazarova
PReS-FINAL-2114: The leptin and adiponectin as biomarkers of atherosclerosis in juvenile rheumatic arthritis
- Open Access
- Poster presentation
V Opoka-Winiarska, J Tabarkiewicz, A Emeryk
PReS-FINAL-2115: Differences in musculoskeletal clinical expression between Spanish and Mexican patients with juvenile spondyloarthritis: data from the Mexespa project
- Open Access
- Poster presentation
WA Sifuentes Giraldo, CA Guillén Astete, ML Gámir Gámir, C Arnal Guimerá, D Clemente Garulo, I Calvo, I Rotes, J Sampedro Álvarez, J García Consuegra, M Medrano, P Collado, R Roldán, S Bustabad
PReS-FINAL-2116: Assessment of disease activity by patients with juvenile idiopathic arthritis and the parents compared to the assessment by pediatric rheumatologists
- Open Access
- Poster presentation
W Armbrust, J Kaak, J Bouma, O Lelieveld, N Wulffraat, P Sauer, E van Sonderen
PReS-FINAL-2117: Dream doctors - medical clowns increase the effect of nitrous oxide sedation in intra-articular corticosteroid injection for juvenile idiopathic arthritis
- Open Access
- Poster presentation
Y Uziel, Y Weintraub, N Rabinowicz, P Hanuka, M Rothschild, S Kotzki
PReS-FINAL-2118: Painless contractures of fingers in a female child
- Open Access
- Poster presentation
A Gagro, AM Kapović, M Žutelija Fattorini, G Krakar, G Roić
PReS-FINAL-2119: United Kingdom survey of current management of juvenile localised scleroderma
- Open Access
- Poster presentation
DP Hawley, CE Pain, EM Baildam, HE Foster
PReS-FINAL-2120: Juvenile scleroderma international network (JUSINET) database: a reliable instrument for clinical research in juvenile scleroderma syndromes
- Open Access
- Poster presentation
G Cuffaro, G Martini, F Sperotto, T Avcin, R Russo, O Kasapcopur, F Vittadello, F Zulian
PReS-FINAL-2121: Results for 6 minute walk values in healthy German children show similar results as from Britain
- Open Access
- Poster presentation
I Foeldvari
PReS-FINAL-2122: Autologous stem cell transplantation in a patient with severe systemic sclerosis in Portugal
- Open Access
- Poster presentation
M Guedes, C Zilhão, L Palhau, I Almeida, I Silva, C Vasconcelos, A Marinho, C Vaz, A Campos
PReS-FINAL-2123: Feto-maternal outcome in patients with systemic sclerosis
- Open Access
- Poster presentation
SE Maher, FM Ismail
PReS-FINAL-2124: Electromyography assessment in localized scleroderma
- Open Access
- Poster presentation
TP Fernandes, TD Fernandes, LFB Angulski, LAL Resende, CS Magalhaes
PReS-FINAL-2125: A Japanese girl with childhood-onset anti-Ku antibody positive generalized morphea-myositis overlap syndrome
- Open Access
- Poster presentation
T Kishi, T Miyamae, A Seki, M Shioda, K Ishigaki, R Morimoto, N Ishiguro, Y Hamaguchi, M Fujimoto, Y Kawaguchi, H Yamanaka, S Nagata
PReS-FINAL-2126: How to follow up children with Raynaud syndrome - recommendations based on the Hamburg consensus meeting 2012
- Open Access
- Poster presentation
T Constantin, C Pain, N Toplak, M Moll, I Konert, DP Piotto, NA Ayaz, D Nemkova, P Hoeger, M Cutolo, V Smith, I Foeldvari
PReS-FINAL-2127: Sclerodermatous graft versus host disease
- Open Access
- Poster presentation
JR Stevenson, C Mcvitty, N Martin, B Gibson, AM Ewins, L Jones, D Shanks, C Grant, M Berry, J Duncan, JE Davidson
PReS-FINAL-2128: Quality of life and psychosocial aspects in juvenile localized scleroderma (JLS): a cross-sectional study in 40 patients
- Open Access
- Poster presentation
R Culpo, M Ricca, F Vittadello, G Sequi, F Zulian, G Martini
PReS-FINAL-2129: Whole-body versus localized magnetic resonance imaging in the assessment of juvenile dermatomyositis
- Open Access
- Poster presentation
A Madeo, MB Damasio, M Dellepiane, A Providenti, D Beleva, A Buoncompagni, A Beltramo, N Ruperto, A Martini, C Malattia
PReS-FINAL-2130: Antibodies to MDA5 correlate with a distinct phenotype in children with juvenile dermatomyositis, including higher risk of lung involvement and ulcerative skin disease
- Open Access
- Poster presentation
E Moraitis, S Tansley, K Arnold, ZE Betteridge, H Gunawardena, TS Jacques, C Owens, LR Wedderburn, N Mchugh
PReS-FINAL-2130-A: Effectiveness of intravenous cyclophosphamide in severe or refractory juvenile dermatomyositis - a national cohort study UK and Ireland
- Open Access
- Poster presentation
E Moraitis, K Arnold, LR Wedderburn, CA Pilkington
PReS-FINAL-2131: Hunting for biomarkers in juvenile dermatomyositis
- Open Access
- Poster presentation
F Bellutti Enders, A Van Royen-Kerkhof, B Prakken, F Van Wijk, R Scholman, W De Jager
PReS-FINAL-2132: Defining criteria for high disease activity in juvenile idiopathic arthritis: definition and validation of juvenile arthritis disease activity score cutoffs
- Open Access
- Poster presentation
A Consolaro, S Verazza, MC Gallo, G Bracciolini, G Negro, A Frisina, N Ruperto, A Martini, A Ravelli
PReS-FINAL-2133: Drug survival and switching of biological agents in systemic juvenile idiopathic arthritis
- Open Access
- Poster presentation
A Woerner, F Uettwiller, I Melki, B Bader-Meunier, R Mouy, C Wouters, P Quartier
PReS-FINAL-2134: Assessment of radiographic progression in patients (pts) with systemic juvenile idiopathic arthritis (sjia) treated with tocilizumab (TCZ): 2-year results from the tender trial
- Open Access
- Poster presentation
C Malattia, N Ruperto, E Palmisani, S Pederzoli, A Pistorio, HI Brunner, R Cuttica, I Calvo, SM Garay, D Eleftheriou, C Wouters, J Wang, C Devlin, D Lovell, A Martini, F De Benedetti, A Ravelli
PReS-FINAL-2135: Analysis of the HLA region in a large cohort of juvenile idiopathic arthritis cases identifies independent effects at HLA-DRB1
- Open Access
- Poster presentation
A Hinks, J Cobb, B Han, MC Marion, M Sudman, P Martin, J Bohnsack, LR Wedderburn, JP Haas, PI De Bakker, CD Langefeld, S Raychaudhuri, S Prahalad, SD Thompson, W Thomson
PReS-FINAL-2137: Adalimumab monotherapy results in clinical and radiological improvement in newly diagnosed patients with juvenile spondylarthritis (JSPA)/enthesitis related arthritis(ERA)
- Open Access
- Poster presentation
D Maritsi, A Soldatou, G Papaioannou, A Garoufi
PReS-FINAL-2138: Abatacept (orencia) in treatment of different types of juvenile idiopathic arthritis
- Open Access
- Poster presentation
ES Zholobova, OU Konopelko, LA Galstyan, OS Rozvadovskaya, MN Nikolaeva
PReS-FINAL-2139: Tapering and withdrawal of tocilizumab in patients with systemic JIA in inactive disease: results from an alternative dosing regimen in the tender study
- Open Access
- Poster presentation
F De Benedetti, N Ruperto, HI Brunner, A Grom, N Wulffraat, M Henrickson, R Jerath, Y Kimura, AK Kadva, J Wang, A Martini, D Lovell
PReS-FINAL-2140: Neutropenia with Tocilizumab (TCZ) treatment is not associated with increased infection risk in patients with systemic juvenile idiopathic arthritis (SJIA)
- Open Access
- Poster presentation
F De Benedetti, HI Brunner, E Baildam, R Burgos-Vargas, G Horneff, HI Huppertz, K Minden, BL Myones, K Onel, J Wang, K Bharucha, D Lovell, A Martini, N Ruperto
PReS-FINAL-2141: Clinical features, therapeutic interventions and outcome of 362 patients with macrophage activation syndrome enrolled in a multinational survey
- Open Access
- Poster presentation
F Minoia, S Davì, A Horne, A Consolaro, S Rosina, Z Davidsone, C De Cunto, J De Inocencio, E Eisenstein, G Espada, M Fishbach, M Frosch, R Gallizzi, ML Gamir, T Griffin, A Grom, T Hennon, G Horneff, Z Huasong, N Ruperto, A Martini, RQ Cron, A Ravelli
PReS-FINAL-2142: Predictors of persistent remission following etanercept (ETN) withdrawal in patients with juvenile idiopathic arthritis (JIA)
- Open Access
- Poster presentation
F Perfetti, F Gesualdo, V Messia, A Insalaco, C Bracaglia, M Pardeo, R Nicolai, L Meli, F De Benedetti, S Magni Manzoni
PReS-FINAL-2143: Treat-to-target strategy in juvenile idiopathic arthritis: experience in 175 newly-diagnosed patients
- Open Access
- Poster presentation
G Negro, A Consolaro, S Verazza, G Bracciolini, S Rosina, R Pignataro, A Civino, A Martini, A Ravelli
PReS-FINAL-2144: Bone mineral status in patients with juvenile idiopathic arthritis after 12 months of treatment with etanercept
- Open Access
- Poster presentation
G Susic, G Radunovic, N Damjanov, D Novakovic, N Djurovic, R Stojanovic
PReS-FINAL-2145: MRP8/14 serum complexes as predictor of response to etanercept treatment in juvenile idiopathic arthritis
- Open Access
- Poster presentation
J Anink, MH Otten, LA Van Suijlekom-Smit, MA Van Rossum, KM Dolman, EP Hoppenreijs, R Ten Cate, T Vogl, D Foell, J Roth, D Holzinger
PReS-FINAL-2146: Trends in prescription of biologics and outcomes of juvenile idiopathic arthritis; results of the Dutch national arthritis and biologicals in children register
- Open Access
- Poster presentation
MH Otten, J Anink, FH Prince, M Twilt, SJ Vastert, R Ten Cate, EP Hoppenreijs, W Armbrust, SL Gorter, PA Van Pelt, S Kamphuis, KM Dolman, JF Swart, JM Van den Berg, Y Koopman-Keemink, MA Van Rossum, NM Wulffraat, LA Van Suijlekom-Smit
PReS-FINAL-2147: Immunological consequences of biologicals in juvenile idiopathic arthritis
- Open Access
- Poster presentation
JF Swart, S De Roock, NM Wulffraat
PReS-FINAL-2148: Rheumates@work a cognitive behavioural internet based intervention promoting physical activity in children with juvenile idiopathic arthritis: preliminary results of a randomized clinical trail
- Open Access
- Poster presentation
J Bos, W Armbrust, J Geertzen, P Sauer, P Dijkstra, M Van Brussel, J Cappon, O Lelieveld
PReS-FINAL-2149: Interaction of PTPN2 and vitamin D GC sequence variants and risk of juvenile idiopathic arthritis
- Open Access
- Poster presentation
JA Ellis, KJ Scurrah, RA Chavez, AL Ponsonby, A Pezic, RC Allen, JD Akikusa, JE Munro
PReS-FINAL-2150: Antiocular antibodies in children with juvenile idiopathic arthritis-associated uveitis
- Open Access
- Poster presentation
K Walscheid, M Hennig, C Heinz, D Bauer, M Dietzel, M Busch, S Wasmuth, D Foell, C Deeg, A Heiligenhaus
PReS-FINAL-2151: HLA B27/B7, TLR-4, NLRP3, CXCR4 AND PTPN12: the shared genetic master-key genes leading to development of undifferentiated spondyloarthritis/era in children
- Open Access
- Poster presentation
L Lamot, M Vidović, L Tambić Bukovac, F Borovečki, K Gotovac, F Bingula, M Harjaček
PReS-FINAL-2152: Biomarkers as predictors of early inactive disease in children with juvenile idiopathic arthritis
- Open Access
- Poster presentation
M Lavric, T Weinhage, J Klotsche, G Horneff, JP Haas, K Minden, D Foell
PReS-FINAL-2153: Intestinal gamma/delta- T cells are upregulated in children with active uveitis
- Open Access
- Poster presentation
M Arvonen, P Vähäsalo, T Karttunen
PReS-FINAL-2154: The early predictors of fatal outcome of macrophage activation syndrome in pediatric rheumatic diseases
- Open Access
- Poster presentation
MM Kostik, NN Abramova, LS Snegireva, LI Vasykina, MF Dubko, VV Masalova, TL Kornishina, TS Likhacheva, IA Chikova, NI Glebova, NV Buchinskaya, OV Kalashnikova, VG Chasnyk
PReS-FINAL-2155: Genetic variability of methotrexate transporters in patients with juvenile idiopathic arthritis
- Open Access
- Poster presentation
M Zajc Avramovič, N Toplak, M Debeljak, M Accetto, L Lusa, V Dolžan, T Avcin
PReS-FINAL-2156: Analysis of gene expression and inflammation biomarkers in systemic juvenile idiopathic arthritis (SJIA) patients on canakinumab therapy
- Open Access
- Poster presentation
N Nirmala, N Wulffraat, H Brunner, P Quartier, R Brik, L Mccann, H Ozdogan, L Rutkowska-Sak, R Schneider, V Gerloni, L Harel, M Terreri, K Houghton, R Joos, D Kingsbury, J Lopez-Benitez, S Radominski, A Brachat, S Bek, M Schumacher, M Valentin, H Gram, K Abrams, A Martini, N Ruperto, D Lovell
PReS-FINAL-2157: Efficacy of canakinumab in the treatment of systemic juvenile idiopathic arthritis: a 12-week pooled post-hoc analysis
- Open Access
- Poster presentation
P Quartier, H Brunner, T Constantin, S Padeh, I Calvo, M Erguven, L Goffin, M Hofer, T Kallinich, S Oliveira, Y Uziel, S Viola, K Nistala, C Wouters, K Lheritier, J Hruska, K Abrams, A Martini, N Ruperto, D Lovell
PReS-FINAL-2158: Effect of canakinumab on functional ability and health-related quality of life in systemic juvenile idiopathic arthritis (SJIA) patients
- Open Access
- Poster presentation
P Quartier, N Ruperto, N Wulffraat, H Brunner, R Brik, L Mccann, H Foster, M Frosch, V Gerloni, L Harel, C Len, K Houghton, R Joos, K Abrams, K Lheritier, S Kessabi, A Martini, D Lovell
PReS-FINAL-2159: Tocilizumab (TCZ) dosing in juvenile idiopathic arthritis (JIA): optimising for different JIA type and body weight patients
- Open Access
- Poster presentation
P Lu, J Hsu, C Keane, S Fettner, J Wang, N Ruperto, O Harari, HI Brunner, F De Benedetti
PReS-FINAL-2160: Intestinal microbiome in polyarticular juvenile idiopathic arthritis: a pilot study
- Open Access
- Poster presentation
PC Hissink Muller, PM Westedt, AE Budding, CF Allaart, DM Brinkman, TW Kuijpers, JM Van den Berg, LW Van Suijlekom-Smit, MA Van Rossum, TG De Meij, R Ten Cate
PReS-FINAL-2161: Safety and effectiveness of adalimumab in children with polyarticular juvenile idiopathic arthritis aged 2 to <4 years or >=4 years weighing <15 kg
- Open Access
- Poster presentation
D Kingsbury, P Quartier, V Arora, J Kalabic, H Kupper, N Mozaffarian
PReS-FINAL-2162: Development of a risk model to predict methotrexate intolerance in juvenile idiopathic arthritis
- Open Access
- Poster presentation
P Van Dijkhuizen, M Bulatovic-Calasan, S Pluijm, M De Rotte, B Vastert, S Kamphuis, R De Jonge, N Wulffraat
PReS-FINAL-2163: Disease activity in a juvenile idiopathic arthritis population after 5 years follow-up
- Open Access
- Poster presentation
R Marques, F Ramos, AF Mourão, F Martins, H Canhão, JE Fonseca, JA Pereira da Silva
PReS-FINAL-2164: Agreement among musculoskeletal pediatric specialists in the assessment of radiographic joint damage in juvenile idiopathic arthritis
- Open Access
- Poster presentation
R Pignataro, AL Rodriguez-Lozano, G Giancane, S Viola, M Valle, S Gregorio, X Norambuena, M Ioseliani, A Pistorio, A Martini, A Ravelli
PReS-FINAL-2165: Pharmacogenetic determinants of response to methotrexate in juvenile idiopathic arthritis
- Open Access
- Poster presentation
S Pastore, V Moressa, G Stocco, G Decorti, L Lepore
PReS-FINAL-2166: Long-term safety and effectiveness of anti-interleukin-6 receptor monoclonal antibody, tocilizumab, in patients with systemic juvenile idiopathic arthritis in Japan
- Open Access
- Poster presentation
S Yokota, T Nozawa, T Kanetaka, K Yamazaki, T Sato, N Sakurai, M Kikuchi
PReS-FINAL-2167: What is the potential of intra-articular corticosteroid injections to induce sustained remission in children with juvenile idiopathic arthritis?
- Open Access
- Poster presentation
S Lanni, F Bovis, C Papadopoulou, M Kostik, MI Gonzalez-Fernandez, M Bohm, JC Nieto-Gonzalez, M Bertamino, A Martini, A Ravelli
PReS-FINAL-2168: Comparison of safety and retention rate of TNF antagonist therapy in juvenile-onset and adult-onset ankylosing spondylitis: data from the spanish registry biobadaser 2.0
- Open Access
- Poster presentation
WA Sifuentes Giraldo, C Guillén Astete, ML Gámir Gámir, S Pérez Vicente, L Carmona, JJ Gómez-Reino
PReS-FINAL-2169: Exposure-response modeling of canakinumab in the avoidance of flares in children with systemic juvenile idiopathic arthritis
- Open Access
- Poster presentation
Y Xiong, W Wang, W Ebling, H Sun, O Luttringer, K Abrams, N Ruperto, H Brunner
PReS-FINAL-2170: Work disability in adult patients with juvenile idiopathic arthritis (JIA)
- Open Access
- Poster presentation
C Goldenstein-Schainberg, J Gordo, R Krieger, LE Paula, N Aikawa
PReS-FINAL-2171: Consensus: what agent to use when first-line vasodilators fail in Raynaud's phenomenon or digital ulcers secondary to rheumatic diseases in children?
- Open Access
- Poster presentation
M Katsicas, M Gonzalez, R Russo
PReS-FINAL-2172: Efficacy of corticosteroids and intravenous cyclophosphamide for patients with juvenile systemic sclerosis
- Open Access
- Poster presentation
M Kikuchi, T Nozawa, T Kanetaka, K Nishimura, R Hara, K Yamazaki, T Sato, N Sakurai, S Yokota
PReS-FINAL-2195: The comparison of the efficacy of once and twice daily dosage of colchicine in pediatric patients with Familial Mediterranean Fever
- Open Access
- Poster presentation
A Polat, C Acikel, B Sozeri, I Dursun, O Kasapcopur, H Peru, I Dokurel, H Poyrazoglu, S Bakkaloglu, A Delibas, Z Ekinci, NA Ayaz, Y Kandur, E Unsal, B Makay, F Gok, S Ozen, E Demirkaya
PReS-FINAL-2196: The clinical significance of the Q703K mutation of NLRP3 gene. A multicentric national study
- Open Access
- Poster presentation
A Naselli, L Cantarini, A Insalaco, M Alessio, A Tommasini, R Gallizzi, S Signa, OM Lucherini, F Caroli, I Ceccherini, A Martini, M Gattorno
PReS-FINAL-2197: Teenage boy suffering from diabetes mellitus type 1 and heterozygous Familial Mediterranean Fever: a case report
- Open Access
- Poster presentation
AN Olivieri, MF Gicchino, C Granato, A Mauro, A Mellos
PReS-FINAL-2198: Insufficient efficacy of tocilizumab therapy in children with Castleman's disease
- Open Access
- Poster presentation
A Kozlova, D Abramov, N Miakova, A Maschan, A Shcherbina
PReS-FINAL-2199: A novel mutation in the CIAS1/NLRP3 gene associated with an unusual phenotype of CAPS
- Open Access
- Poster presentation
A Insalaco, G Prencipe, PS Buonuomo, I Ceccherini, C Bracaglia, M Pardeo, R Nicolai, F De Benedetti
PReS-FINAL-2200: Phenotype of V198M and Q703K NLRP3 variants
- Open Access
- Poster presentation
V Messia, M Pardeo, R Nicolai, C Bracaglia, F De Benedetti, A Insalaco
PReS-FINAL-2201: A P268S NOD mutation in one Blau patient
- Open Access
- Poster presentation
M Pardeo, E Cortis, C Bracaglia, R Nicolai, F De Benedetti, A Insalaco
PReS-FINAL-2202: A novel PSMB8 mutation associated with CANDLE syndrome
- Open Access
- Poster presentation
A Insalaco, V Messia, M Pardeo, R Nicolai, C Bracaglia, F De Benedetti
PReS-FINAL-2203: Assessment of sleep problems in children with familial Mediterranean fever
- Open Access
- Poster presentation
B Makay, SK Kılıçarslan, A Anık, E Ünsal
PReS-FINAL-2204: Developing of a new scale for assessing the adherence to colchicines treatment in pediatric patients with FMF
- Open Access
- Poster presentation
S Yesilkaya, C Acıkel, B Eren Fidanci, B Sozeri, N Aktay Ayaz, N Akıncı, G Ozcelik, S Kavukcu, Ü Aydogan, S Ozenc, S Emre, O Donmez, S Yuksel, A Delibas, A Berdelli, H Poyrazoglu, M Saldir, N Cakar, H Peru, S Bakkaloglu, Y Tabel, O Sari, A Polat, G Basbozkurt, E Unsal, F Gok, O Kasapcopur, S Ozen, E Demirkaya
PReS-FINAL-2205: Vascular risk assesment and MMP-3 gene in FMF
- Open Access
- Poster presentation
B Sozeri, S Mir, K Ozdemir, A Berdeli
PReS-FINAL-2206: Clinical experiences in patients with chronic recurrent multifocal osteomyelitis (CRMO)
- Open Access
- Poster presentation
B Sozeri, B Yildiz, M Sezak, M Argin
PReS-FINAL-2207: Results from a multicenter international registry of Familial Mediterranean Fever: validation of the new set of pediatric diagnostic criteria
- Open Access
- Poster presentation
E Demirkaya, S Ozen, C Saglam, T Turker, A Duzova, P Woo, I Konè-Paut, M Doglio, G Amarian, J Frenkel, Y Uziel, A Insalaco, L Cantarini, M Hofer, S Boiu, C Modesto, A Bryant, D Rigante, E Papadopoulou-Alataki, S Guillaume-Czitrom, N Ruperto, M Gattorno